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CHAPTER 0 NE 
INTRODUCTION AND LITERATURE REVIEW 
SPONDYLOARTHROPATHY 
Seronegative spondyloarthropathy (1) is a term introduced in 
1974 to describe a group of interrelated arthritides charac-
terised by the following features (2) : 
spinal (including sacroiliac joint) involvement 
enthesitis 
asymmetric peripheral arthritis of predominantly the 
lower limbs 
familial tendency 
negative rheumatoid factor, and an 
Human Leukocyte Antigen (HLA)-B27 association. 
This was amended to spondyloarthropathy later with the recog-
nition that a small percentage of normal adult populations 
worldwide are rheumatoid factor positive, and that the 
prevalence thereof increases with advancing age (3). 
1.1 Traditional spectrum of disease 






reactive arthritis, including Reiter's syndrome. 
Classification and/or diagnostic criteria are well 
established for the above subgroups and are detailed in 
Appendix A (p.82-86). 
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1.2 Undifferentiated spondyloarthritis 
Recently it has been recognised that the rigid confines 
of the spondyloarthropathy complex, as outlined above, 
artificially restrict the existing disease spectrum ( 15). 
Consequently, some spondyloarthropathy patients lacking 
sufficient traditional criteria for one or other of the 
well-defined subgroups, have been excluded from 
epidemiological and clinical studies (16,17). The 
European Spondyloarthropathy Study Group ( ESSG) addressed 
this issue in 1991 ( 15). They proposed preliminary 
criteria for the purpose of identifying the broader 
spectrum of spondyloarthropathies (Appendix B, p.87). 
These criteria serve particularly to include the 
previously excluded group, which is now referred to as 
undifferentiated spondyloarthropathy. Inclusion of 
patients fulfilling criteria for undifferentiated 
spondyloarthropathy in current and future studies helps 
in identification of patterns of disease expression and 
understanding of the natural history of the disease. 
The likelihood exists that concepts long adhered to in 
the previously restricted spondyloarthropathy spectrum 
would need to be significantly altered. 
two examples emphasise this point 
The following 
(a) Isolated circumpolar Eskimo populations have an 
exceptionally high background prevalence of HLA-B27, 
of the order of 25-40% (18). A community-based 
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study of this group (19) demonstrated a 1.3% 
prevalence of spondyloarthritis in 464 patients 
examined. This is strikingly higher than the 
widely quoted prevalence of O. 2% for ankylosing 
spondyli tis in Caucasian populations world-wide 
(17), and reflects the high HLA-B27 prevalence in 
Eskimos. Interestingly in this study, the 
prevalence of ankylosing spondylitis, reactive 
arthritis and undifferentiated spondyloarthritis 
was similar. Thus undifferentiated spondylo-
arthropathy, previously ignored, may assume the 
same status as ankylosing spondylitis in the 
broader spectrum of spondyloarthropathy, at least 
in certain populations. 
(b) Amongst patients with undifferentiated spondylo-
arthritis, 
long-term 
reviewed by Zeidler et al 
follow-up study, 25-59% 
(16) in a 
developed 
ankylosing spondylitis within a ten-year period. 
As the authors suggest, the term undifferentiated 
spondyloarthri tis is best considered a working 
diagnosis while this subgroup undergo further study 
in terms of pathogenesis and disease expression. 
Clearly there is an ongoing need to study this parti-
cular subgroup of spondyloarthropathies more carefully. 
1.3 Juvenile-onset spondyloarthritis 
HLA-B27 associated rheumatic diseases of childhood onset 
also form part of the spondyloarthropathy complex, and 
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include juvenile-onset ankylosing spondyli tis, psoriatic 
arthritis, enteropathic arthritis and reactive arthritis 
( 20) . These conditions are often diagnosed retro-
spectively, since axial involvement (both clinically and 
radiologically) is present in less than one-quarter of 
patients at onset of disease ( 21), and the inter-
pretation of radiographic sacroilii tis is limited by 
normal growth in childhood which causes blurring of the 
sacroiliac joint margins per se (22). 
Owing to these limitations, the diagnosis of juvenile 
spondyloarthritis is best considered within the broad 
con:text of the seronegati ve enthesopathy and arthropathy 
(SEA) syndrome (23). The SEA syndrome includes all 
rheumatoid factor negative children, aged 16 years or 
less, presenting with arthralgia (in the presence or 
absence of objective signs of synovitis) and enthesitis. 
Long-term follow-up of these children, presenting with 
a constellation of musculoskeletal complaints for which 
a clinical diagnosis is not immediately apparent, has 
shown that a significant proportion go on to develop 
features characteristic of one or other spondylo-
arthropathy disorder. This is well illustrated by a 
recent study in which 75% of children presenting with an 
initial diagnosis of SEA syndrome, developed sufficient 
clinical and radiographic axial features to satisfy a 
diagnosis of ankylosing spondylitis within five years of 
disease onset (24). 
2. 
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Thus, as in adults, the spondyloarthritis spectrum has 
been expanded so as to identify as many clinically 
relevant patients as possible. This affords future 
research opportunities already alluded to in the context 
of adult-onset disease. 
THE HLA-B27 ASSOCIATION 
An association of the HLA-B27 (class I) antigen and spondylo-
arthropathy disorders, was described more than twenty years 
ago (25,26). In most Caucasian populations with ankylosing 
spondylitis, more than 90% of cases are HLA-B27 positive (27, 
quoted in 5). This contrasts strikingly with the general 
HLA-B27 prevalence in Caucasians of about 8% (27, quoted in 
5) • 
A similar but slightly less striking association, (about 80% 
in most cases) , has also been demonstrated in reactive 
arthritis (28,29). 
In psoriasis and inflammatory bowel disease, spondyli tis 
accompanied by sacroiliitis is almost as tightly associated 
with HLA-B27 as is ankylosing spondyli tis. Peripheral 
arthritis in this setting is, however, not as closely 
associated with HLA-B27 (30). 
In view of the strong overall HLA-B27 association, the 
spondyloarthropathies are referred to by some as HLA-B27-
associated diseases in order to highlight the pivotal role 
that the histocompatibility antigen plays (30). 
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It is well recognised that the disorders, in particular 
ankylosing spondylitis, may also occur in the absence of HLA-
B27 (31-34). This is true of population groups where the 
background prevalence of HLA-B27 is low, including 
genetically unmixed native populations of South America, 
Blacks and San Bushmen of Equatorial and Southern Africa, 
Aborigines of Australia, and people of the Eastern Polynesian 
Islands and Japan (35,36). 
Black Americans have a background prevalence of HLA-B27 in 
the order of 2-4% ( 32, 37) as compared to the previously 
quoted figure of 8% for American Caucasians. Only about 50% 
of American Blacks w_i th ankylosing spondyli tis are HLA-B27 
positive (32), compared to more than 90% of Caucasian 
ankylosing spondylitis subjects. In circumstances of 
reduced HLA-B27 prevalence therefore, the association with 
ankylosing spondylitis is less impressive and the prevalence 
of HLA-B27 negative disease is correspondingly greater (17). 
This phenomenon is not restricted to Black populations, but 
has also been observed in certain European Caucasian groups; 
for example, an HLA-B27 prevalence of only 42.8% was recorded 
in ankylosing spondylitis subjects identified in a Dutch 
population survey (38). 
The occurrence of spondyloarthropathy in the absence of an 
association with HLA-B27 has raised the question of clinical 
differences based on HLA-B27 status. This has been exten-
sively debated in the literature, and the data to date has 
been reviewed by Linssen and Feltkamp (30). They conclude 
that in ankylosing spondylitis, aside from the positive 
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association of acute anterior uvei tis with HLA-B27, the 
clinical and radiographic differences ascribed to HLA-B27 
status largely reflect patient selection. Studies of 
ankylosing spondyli tis in which patients with spondyli tis 
associated with psoriasis and inflammatory bowel disease were 
included (39,40), tended to indicate a later age of disease 
onset, and a milder clinical course (judged by the 
development of 'bamboo spine' changes on radiographs) in HLA-
B27 negative indi victuals. However, carefully conducted 
studies in North America (33) and Europe (34), which only 
included primary ankylosing spondylitis cases, failed to show 
any differences in age of onset, prevalence of peripheral 
arthritis, severity of pain and disability or spinal radio-
logical abnormalities which could be ascribed to HLA-B27 
status. These studies demonstrated the positive association 
between acute anterior uveitis and the presence of HLA-B27 
antigen, and the absence of a relevant family history of 
spondylitis-associated 
subjects. 
disorders in HLA-B27 negative 
Among reactive arthritis patients, including those with 
features of Reiter's syndrome, those positive for the HLA-B27 
antigen show clinical heterogeneity reflected in increased 
severity and duration of peripheral arthritis (41-43), more 
frequent mucocutaneous features (42,44), an increased 
prevalence of back pain, radiological sacroiliitis and acute 
anterior uveitis (41-43) as well as a greater tendency to 
chronicity or a relapsing clinical course (44,13). 
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3. BACTERIAL PATHOGENS AND SPONDYLOARTHROPATHY 
HLA-B27 associated reactive arthritis, aetiologically linked 
to a variety of microbial pathogens, serves as a good 'human 
disease model' ( 45) and has become the focus of intense 
research from which clues to the pathogenesis of other 
arthropathies could arise. Micro-organisms which are 
causally associated with reactive arthritis include 
Shigella f lexneri ( 46), Salmonella enteritidus {47 ,48), 
Salmonella typhimurium (49), Yersinia enterocolitica (14), 
Yersinia pseudotuberculosis (14), Campylobacter jejuni 
( 50, 51) and Chlamydia trachomatis ( 52) . In most 
circumstances the infective aetiology is underscored by the 
presence of bacterial antigenic_ material in synovial tissue 
and/or synovial fluid. The cumulative data have been 
reviewed by Hughes and Keat recently (45). 
Additionally, polymerase chain reaction (PCR) amplification 
to detect Chlamydial deoxyribonucleic acid {DNA) in a cohort 
of undifferentiated spondyloarthritis patients was performed 
in 1995 (53). In 41% of 27 synovial fluid samples taken 
from patients with no preceding history of urethritis, PCR 
amplification for Chlamydia trachomatis DNA was positive. 
These patients were all considered to have undifferentiated 
spondyloarthritis clinically, with no history to suggest an 
episode of reactive arthritis. This is exciting, since it 
suggests that an infective aetiology may also explain the 
pathogenesis of undifferentiated spondyloarthropathy. 
Proof of infection as a trigger to reactive arthritis, and 
possibly undifferentiated spondyloarthritis too, raises the 
4 . 
9 
possibility of antimicrobial therapy as definitive treatment. 
This avenue has long been explored: early studies have been 
reviewed by Hughes and Keat ( 45), who conclude that initial 
isolated reports of success with antibiotic treatment were 
largely anecdotal. Recent studies look more promising: the 
use of antibiotic therapy for recurrent urethritis in a 
Greenland population resulted in a significant reduction in 
the recurrence of reactive arthritis in treated patients 
(54), whilst the extended use of lymecycline (for a period of 
three months) shortened the duration of joint features in 
post-Chlamydial reactive arthritis (55). These findings 
support the notion that reactive arthritis may be treatable 
by definitive means, and thus holds prospect for potentially 
curable therapy. In light of this, traditional therapeutic 
approaches stand on the brink of change, and reflect the 
paradigm shift that the management of spondyloarthropathy is 
currently undergoing (56). 
SPONDYLOARTHRITIS IN AFRICA. AND SOUTH AFRICA IN PARTICULAR 
The prevalence and nature of rheumatic disorders in general, 
and spondyloarthropathies in particular, have been insuffi-
ciently documented from Africa ( 57). Only 20 cases of 
ankylosing spondylitis in Black Africans were known to the 
international community by 1980 ( 58-61). In view of the 
reduced HLA-B27 gene frequency, it is reasonable to assume 
that the prevalence of spondyloarthropathies in African 
Blacks would differ from populations with higher gene 
frequencies. It might also be considered plausible that the 
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data from American Blacks would reflect the situation in 
Africa. However, owing to racial admixture of about 15% 
among American Blacks (62), the background HLA-B27 prevalence 
of 2% (32) is significantly higher than the recorded values 
in Black Africans of Xhosa (0.83%) and Zimbabwean (0.68%) 
origin respectively (63). It is thus reasonable to predict 
that spondyloarthropathies in Africans would be poorly 
associated with HLA-B27 and less frequently seen. However, 
this remains largely unsubstantiated owing to the lack of 
facilities dedicated to the study and care of rheumatic 
diseases in Africa (57). 
Nevertheless, in the last few years reports of spondylo-
arthropathy from sub-Saharan Africa have appeared in the 
literature ( 64-70) . The numbers are small by comparison 
with series from Europe and North America, but it is apparent 
that the diseases are not as rare as previously believed. 
Studies suggest a pattern in Black Africans of advanced 
ankylosing spondylitis without extra-articular manifest-
ations, and predictably the majority of patients are HLA-B27 
negative (59,61,67). 
Psoriasis-related arthritis is rare in Black Africans (71), 
and the same holds true for inflammatory bowel disease (IBD)-
related arthropathy (72). 
Reactive arthritis and undifferentiated spondyloarthropathy 
in the African context are particularly interesting. 
Despite an abundance of urogenital and enteric pathogens 
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(known to be associated with the development of reactive 
arthritis), rheumatic sequelae of infections at these sites 
are not common (64-68,70). In a ten-month study conducted 
to identify all patients evaluated for rheumatic disease-
related complaints at an academic referral hospital in 
Harare, Zimbabwe, only 3% of 411 patients had reactive 
arthritis (68)1 
Reactive arthritis is known to complicate the course of human 
immunodeficiency virus (HIV) infection ( 73, 74), · and in the 
face of the Acquired Immunodeficiency Syndrome (AIDS) 
epidemic in Africa, reactive arthritis in HIV-infected 
individuals may be expected to emerge as an increasingly 
important rheumatological manifestation. Early data from 
Zimbabwe (75,76) and Togo (70) suggest this, but the data is 
sparse compared to the size of the population at risk. Once 
again, the lack of HLA-B27 association is evident (75) and 
may partly explain the relatively infrequent occurrence of 
reactive arthritis in Black Africans with AIDS. 
South African spondyloarthropathy data is restricted to a 
handful of reports [see (a)-(e) below], creating the 
impression that spondyloarthropathies do not impact signifi-
cantly on the health of local communities. 
(a) An epidemiological survey of rheumatic disorders amongst 
urban and rural Blacks in the early 1970s identified 
only one case of ankylosing spondylitis in 1352 adults 
examined (58). The patient was a 62-year-old male. 
His HLA-B27 status was not known. 
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(b) A case report describing a Xhosa father and daughter 
with ankylosing spondylitis. Both subjects were HLA-
B27 positive (59). 
(c) A case series of eight Zulu Blacks (one female) from 
Natal with ankylosing spondylitis. Only one patient 
was HLA-B27 positive (61). 
(d) Two case reports of Reiter's syndrome occurring in Black 
males. One of the subjects was HLA-B27 positive 
(64,65). 
(e) A case series of psoriatic arthritis patients (White and 
Coloured) identified in a cohort of psoriasis patients 
attending a large university dermatology clinic. 42% 
of 58 patients had rheumatologic manifestations (77). 
Such limited information does not do justice to the spectrum 
of disease managed in the health care facilities of South 
Africa. Furthermore, South Africa uniquely lends itself to 
the study of the disorders classified as spondyloarthropathy 
because the country has better established health care 
facilities in general, and rheumatology services in parti-
cular, when compared to most other African countries. 
Most significantly, since HLA-B27 prevalence varies from 
extremely low to high, given the rich genetic diversity of 
the local population (Table 1), South Africa provides a 
potentially unique opportunity to explore the genetic pre-
disposition to, patterns of, and aetiological relationships 
with the spondyloarthropathies in the spectrum as outlined 
earlier in this chapter. 
13 
TABLE 1 HLA-B27 prevalence in South Africans of different 
ethnic origins 
ETHNIC ORIGIN HLA-B27 REFERENCE(S) 
PREVALENCE (%) 
San Bushmen Unrecorded 35 
Black (Xhosa) 0.29-0.83 63, 78 
Coloured (Malay)* 2.9 63 
Coloured (non-Malay)** 4.8 63 
White*** 7.8-11.6 63, 78 
Indian**** 2.21 # 
• Descendants ot unions between Khoisan ( Hottentot and Bushmen) , Whites, Malay and Black slaves { 79) 
•• Descendants ot unions between Khoisan (Hottentot and Bush.men), Whites and Black slaves ( 79) 
••• Descendants ot Dutch, French, German and British imm.igranes ( 79) 
**** Descendants of lmdgrants tron. Indian subcontinent 
I Professor G Mody: Spondyloarthropathies - talk at "Rheumatology Pocus" Conference, J ohannesburg, 22 June 1996. 
It is against this background that a study was designed to 
evaluate the clinical spectrum of spondyloarthri tis at a 
referral centre representing a South African population. 
C H A P T E R T W 0 
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1. OBJECTIVES 
2. STUDY DESIGN 
3 . STUDY METHODS 
3.1 Case selection 
3.2 Case exclusion 
3.3 Data capture 
4. ETHNICITY 
5. DEFINITIONS 
6. STATISTICAL ANALYSIS 
7. SHORTCOMINGS OF THIS STUDY 
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CHAPTER TWO 
STUDY DESIGN AND METHODS 
1 . OBJECTIVES 
2 . 
Given the paucity of epidemiological and clinical data 
representing the South African experience with the spondylo-
arthropathies, a study was designed to achieve a description 
of the spectrum of spondyloarthropathy in patients of 
different ethnic origin attending the Rheumatic Diseases Unit 
(RDU), University of Cape Town (UCT), in respect of 
differences in: 
clinical and/or radiographic expression of disease; 
gender 
HLA-B27 status, and 
choice of therapy and requirements for reconstructive 
orthopaedic surgical procedures. 
STUDY DESIGN 
The study comprised a retrospective descriptive review of all 
new cases of spondyloarthropathy seen at the RDU, UCT Medical 
School, from 1 January 1988 to 31 December 1994, who were 
consecutively identified from an analysis of the clinical 
records. 
The RDU (UCT) is one of two principal referral centres for 
rheumatic-related diseases in the Western Cape region, and 
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provides clinical services at Groote Schuur Hospital (GSH, 
Observatory) and Princess Alice Orthopaedic Hospital (PAOH, 
Retreat) in Cape Town for an estimated population of 3. 4 
million (Western Cape), 55% (1.9 million) of whom are 
resident in the Cape Peninsula region (81). A minority of 
patients from further afield (Northern Cape and Eastern Cape) 
also attend the unit. 
Approximately 12 500 patients attend PAOH outpatient 
Department (OPD) annually, of which 35% are seen by the RDU 
staff each year (average values calculated from attendance 
registers for the period 1 January 1988 to 3_1 December 1994). 
New patients consti~ute about 6% of all patients seen by the 
RDU per annum (Table 2). Statistical data were not 
available from the OPD Arthritis Clinic (AC) at GSH, but 
similar proportions would be expected, since both clinics are 
staffed by the same complement of doctors and operate under 
similar circumstances at both venues. 
TABLE 2 PAOH Outpatient Department statistics 
Outpatients seen per annum 
mean (range) 
All OPD clinics 12 525 
RDU OPD clinics 4 255 (4130-4617) 
RDU new patients 275 (195-346) 
3. STUDY METHODS 
3.1 Case selection 
For the period 1988-1994, potential cases of spondylo-
arthropathy were identified by computer-assisted search 
of an established database maintained at PAOH. All 
patients in whom one of the following diagnoses was 








Additional potential cases were also selected from 
amongst patients attending the outpatient AC at GSH. 
A dedicated rheumatic diseases database did not exist at 
this facility at the time of study, and precluded a 
systematic search to identify all suitable patients. 
Only patients identified in the course of routine clinic 
visits could be considered for study. 
The clinic records of 120 potential cases identified 
were subject to review by the investigator, and 100 
cases were identified for further study. 
3.2 Case exclusion 
Figure 1 indicates the reasons for exclusion of 20 
potential cases by virtue of wrong diagnosis, in-









Figure 1 Reasons for exclusion from study 
(a) Wrong diagnosis Fibromyalgia (2), unspecified 
arthralgia (4), seronegative rheumatoid arthritis 
(RA) ( 3 ) and gout ( 1) . 
( b) Insufficient data Three cases of ankylosing 
spondylitis referred to PAOH during the study 
period were seen by the Department of Orthopaedic 
Surgery with a view to arthroplasty surgery. These 
patients did not undergo full rheumatological 
evaluation by a staff member of the RDU since such 
had been done at another facility. This 
information was not available in the PAOH notes. 
The case folders of a further two patients could 
not be traced. 
( c) Disputed diagnosis Three cases of presumed 
ankylosing spondylitis were rejected because 
advanced age of disease-onset raised concern 
regarding the possible diagnosis of diffuse 
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idiopathic skeletal hyperostosis (DISH ) , a non-
inflammatory arthropathy occurring predominantly in 
aging males (80). 
(d) Post-infectious sequelae not usually recognised as 
part of the reactive arthritis spectrum ( 11) : One 
patient had post-rubella synovitis of the wrists, 
and another had post-streptococcal synovitis. 
3.3 Data capture 
A data capture sheet was designed to record demographic, 
historical, clinical, serological, radiological, 
microbiological and management-related details ( Appendix 
c, p.88-91). All recorded information was obtained 
from clinic records kept from the time of initial 
patient evaluation until last seen or the time of data 
collection (March-May 1995), whichever occurred first. 
Clinic records kept by the RDU reflect clinical, radio-
logical and special investigation(s) findings from the 
time when first seen in a 'New Patient' clinic were 
evaluated by a senior house officer or medical 
registrar, undergoing training in rheumatic-related 
diseases, and reviewed by a consultant rheumatologist. 
Periodic review by the consultant staff at follow-up 
visits is achieved as required. The typewritten 
records thus largely reflect the opinion of a consultant 
rheumatologist, and were particularly suitable ( detailed 
and legible) for purposes of retrospective data review. 
19 
Each selected case was assigned a clinical diagnosis 
from within the spondyloarthropathy spectrum according 
to well-established definitions and/or diagnostic 
criteria contained in Appendices A and B: 
4. ETHNICITY 
ankylosing spondylitis (AS) 
psoriatic arthritis (PsA) 
enteropathic arthritis (EA) 
reactive arthritis (ReA)* 
undifferentiated spondyloarthritis (USpA). 
* including Reiter's syndrome. 
Note was taken of the race of the patient as defined in the 
hospital administration records, and patients were thus 
defined as Black, White, Coloured or Asian. 
The term 'Asian' as used in this study refers to Indian 
people (largely South African by birth) whose forefathers 
originally emigrated from the Indian subcontinent in the last 
century to take up residence in South Africa, and is used to 
conform to race classifications used in South African 
population statistics. 
In this study 'Coloured' is taken to mean South Africans of 
mixed ethnic origin, who are of Malay or non-Malay descent 
(refer to Chapter One: Introduction and Literature Review -
Table 1, page 13), as described by Botha and Pritchard (79). 
Clinic records do not permit accurate distinction of these 
two Coloured subgroups, and so all patients of mixed ethnic 
origin are simply referred to as 'Coloured'. 
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An estimate of the expected racial-mix of the group studied 
here was derived through analysis of : 
(a) the population composition of the Western Cape, and more 
specifically of the Cape Peninsula (Figures 2(a) and 
( b)) 
(b) the racial-mix of patients attending the OPDs of the 
major State-funded hospitals in the Cape Peninsula 
(Table 3), and 
(c) the racial-mix of patients attending the RDU 'New 
Patient' clinics at PAOH. 






Figure 2(a) Population composition - Western Cape 1991 (81) 






Cape Peninsula~ magisterial districts of Cape Town, Bellville, Goodwood, Simon's Town and Wynbe
rg 
( including Khayelitsha, Nyanga , Guguletu, Athlone, Mitchell's Plain) 
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Figure 2(b) Population composition - Cape Peninsula 
1991 (81) 
From this data it is seen that during the period of interest, 
Coloured people made up at least 50% of the regional popula-
tion, while Whites comprised about one-quarter and Blacks 
about one-fifth. Asians (largely Indians) comprised a small 
minority of less than 2%. Regarding the data relating to 
Black people, it is highly probable that the population head 
count significantly underestimated the actual figures, owing 
to the difficulties in obtaining correct data in the setting 
of large communities of informal housing (squatter camps), 
political unrest and violence, and an ever-increasing influx 
of Black people from the rural areas of the former Transkei 
and Ciskei. Thus a figure of 22%, although a useful guide, 
has to be viewed with caution, since it largely represented 
Blacks housed in formal settlements at the time of the 1991 
population census. 
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TABLE 3 outpatient head count per population group attending Cape 
























127 259 26.1 
105 861 5.8 
58 529 23.3 
12 525 30.6 
21 941 39.6 
963 164 16.1 
503 192 24.6 
1 589 595 13.1 























• •• Average values calculate d exclude~ PAOH and False Bay Hospital beca:;.se separate non- White racial stati s~ i cs were not available. 
The racial-mix of patients attending state-funded hospital 
OPDs was roughly proportional to that of the overall 
population composition. It may be presumed that Whites were 
under-represented at State hospitals since the more affluent 
sector were likely to attend private medical facilities. 
The inflated Coloured/Asian figure represented combined data, 
while the 21.5% figure for Blacks reflected data similar to 
that obtained from population statistics. Only one hospital 
5. 
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(Tygerberg, Bellville) was able to provide a statistic for 
Asian patients, and this value reflected a similar minority 
figure to that obtained from local population data. 
Analysis of the racial-mix of patients attending the RDU 'New 
Patient' clinics, showed that 180 Black patients were seen in 
the seven-year study period. Thus about 10% (26 of 275 per 
year) of new referrals per annum were Black patients. Data 
for the other race groups could not be accurately defined 
from the patient booking/attendance registers. 
Based on analysis of the presented data, it was estimated 
that the racial-mix of the group of spondyloarthropathy 
patients studied would - be in the order of : 
TABLE 4 
DEFINITIONS 












All terms used in the data capture sheet relating to 
clinical, radiological and seriological features are defined 




All information gathered was entered on a personal computer 
(486DX, IBM-compatible) using the spreadsheet facilities of 
Quattro Pro version 5. 00. Statistical methods of choice 
were based on sample size. Continuous variables were 
compared using the Student's t-test, for variables of equal 
or unequal variance, as appropriate. Chi-squared analysis 
was used for evaluation of categorical data. The assessment 
of significance of differences was determined at a 
probability of 95%. 
7. SHORTCOMINGS OF THIS STUDY 
Retrospective studies, having multiple problems and 
inadequacies, are not well suited to study specific issues of 
interest. Rather, they serve as a useful tool to gain 
initial insight into previously poorly documented problems, 
and thereby promote further prospective study of identified 
matters of importance. To that end this retrospective study 
provides some useful clinical data relating to the spondylo-
arthritis (SpA) disease spectrum as seen in an urban South 
African setting. However, the findings of this study can only 
be evaluated once the reader is familiar with the limitations 
of the work presented. 
(a) Incomplete data capture: The absence of a database 
facility at GSH, at the time of study, precluded 
inclusion of all new SpA patients evaluated by the RDU, 
and thus the findings of this study largely reflect a 
cohort of patients seen at PAOH. 
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Since prospective patient evaluation, according to a 
study protocol, was not performed, all investigations 
(radiological, serological and microbiological) of 
interest were not performed in every case, causing a 
series of missing data in the results. 
( b) Small subgroup sizes: An obvious consequence of 
(c) 
incomplete data capture is a reduction in the number of 
cases within any specific disease/ethnic subgroup. 
Such small subgroups, lacking statistical power, 
frustrate data interpretation in some situations in this 




A hospital OPD-based study tends to 
at the severe end of the disease 
spectrum. This is clearly not an ideal situation, but 
in the absence of any other local data, information such 
as is obtained from this study is useful to define at 
least an initial impression of local disease patterns. 
(d) Poor documentation of the aetiology of ReA: Synovitis 
(oligoarticular, asymmetric) in the absence of any other 
obvious cause (such as sepsis, gout or trauma), accom-
panied by an appropriate history, was sufficient to make 
a diagnosis of ReA in this study. Unfortunately, in 
routine clinical practice, precipitating aetiological 
infections were not pursued in the majority. Thus the 
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aetiology of ReA remains unanswered by this study, but 
interesting future research options are highlighted in 
the discussion text. 
( e) Absence of HLA-B27 subtyping: Nine HLA-B27 subtypes are 
currently recognised (35), and it is apparent that the 
frequency of any given one varies within different 
population groups. There is, however, uncertainty 
regarding the association, or lack thereof, with certain 
subtypes of SpA (discussed in detail in Chapter Four: 
Discussion 1: SpAs are uncommon in Black South 
Africans, p.58-63). Given the enormous genetic 
diversity in south Africa (alluded to in Chapter One: 
Introduction and literature review - 4. SpA in Africa, 
and south Africa in particular, p.12), accurate survey 
of HLA-B27 subtypes in the patients in this study may 
have been expected to yield particularly interesting 
results. 
( f) Poor characterisation of the distribution of small joint 
arthritis: Distinct clinical patterns of joint disease 
in PsA are well described (9): (i) predominant involve-
ment of distal interphalangeal joints, (ii) arthritis 
mutilans, (iii) symmetric polyarthritis, (iv) asymmetric 
oligoarticular arthritis and (v) axial involvement. 
Unfortunately the data collection technique in this 
study did not permit detailed analysis of the patterns 
of joint disease in PsA patients. Such data may have 
been useful to evaluate and compare local disease 
patterns with those highlighted above. 
C H A P T E R T H R E E 
RESULTS 
For ease of comprehension on the part of the reader, the results 
of the study are reported under the headings 
I. Patterns of disease - the broad picture 
II. Influence of ethnicity on patterns of disease 
(Appendix E) 
III. Influence of gender on patterns of disease 
(Appendix F) 
IV. Influence of HLA-B27 on patterns of disease 
(Appendix G) 
Differences observed are highlighted in each subchapter, whilst 
the overall results of the survey, for detailed perusal, are 
provided in the form of tables and figures in complementary 
appendices. 
I. PATTERNS OF DISEASE - THE BROAD PICTURE 
1 . PREVALENCE 
2. DEMOGRAPHY 
3. FAMILY HISTORY 
4. AGE OF DISEASE-ONSET, PRESENTATION AND DURATION 
5. PATTERNS OF DISEASE 
5.1 Spondylitis 
5.2 Peripheral arthritis 
5.3 Tenosynovitis and enthesitis 
5.4 Extra-articular manifestations 
6. LATE COMPLICATIONS 
7. HLA-B27 STATUS 
8 • LABORATORY AND RADIOGRAPHIC DATA 
8.1 Rheumatoid factor 
8.2 Microbiological evaluation 
8.3 Spinal radiographs 
8.4 Sacroiliac joint radiographs 
8.5 Peripheral joint radiographs 
9. MANAGEMENT 
9.1 Medical therapy 
9.2 Orthopaedic surgical procedures 
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I. PATTERNS OF DISEASE - THE BROAD PICTURE 
1 . PREVALENCE 
100 Patients were identified as having spondyloarthropathy, 
and fell into disease groups as depicted in Figure 3. Nine 
patients in the cohort had juvenile-onset disease ( AS=J, 
PsA=4, USpA=2). The diagnosis was made retrospectively in 
seven cases presenting initially in early adulthood. Only 
two PsA patients were seen at disease-onset. Two cases 
classified as USpA when first seen in early adulthood, would 
have been considered to have had SEA syndrome if seen at 
disease-onset in adolescence. 
90% of the selected cases came from PAOH. Therefore, 
spondyloarthropathy patients constitute about 5% of all new 
patients seen annually by the RDU at PAOH; expressed as a 
ratio, about 1:20 new patients seen can be expected to have 












Figure 3 : Spondyloarthropathy disease subgroups 
- Ankyloaing spondylitis (AS): 32 fultilled the lfev York =iteria and 3 fulfilled the Rome criteria i n the 
absence of sacroiliac j oint radiograpll reports (Appendix A) 
- Psoriatic arthritis (PsA) : Appendix A 
- l!!nteropathic arthritis (!!Al : Appendix A 
- Reactive arthritis (ReA) : Fan et al (11) in Appendix A 
- tlndifferentiated spondyloarthropathy (OSpA) : 2SSG =iteria (Appendix Bl 
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2 . DEMOGRAPHY 
White and Coloured patients were well represented in the 
study cohort ( 93%), while the paucity of Black and Asian 







TABLE 5 Demography 
MALES (n=71) 
53 
10 20 30 40 50 60 
Number of patients 
Ethnic composition of spondyloarthritis 
study group 
of 100 spondyloarthropathy patients 
FEMALES (n=29) 
AS PsA EA ReA USpA AS PsA EA ReA UspA 
Black 
3 2 (n=5) 
White 
11 8 4 5 (n=40) 2 6 1 3 
Coloured 
15 11 1 5 4 (n=53) 4 8 1 1 3 
Asian 
2 (n=2) 
29 21 1 11 9 TOTAL 6 14 1 2 6 
3. 
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overall male dominance was demonstrated by a male:female ratio of 
2.5:1, which was prominent in AS (4.8:1) and ReA (5.5:1), 
relatively unimpressive in PsA (1.5:1) and USpA (1.5:1), 
and equal in EA males and females (Table 5). 
FAMILY HISTORY 
Although 22 of the patients reported a family history of 
arthritis, only 8 ( 4 Whites and 4 Coloureds) had a history 
relevant to the index disease case, specifically 
AS : one case with a family history of AS 
PsA 5 cases with family histories of psoriasis 
USpA: one case with a family history of IBD and one 
with a family member having AS. 
The remaining 14 patients reported a family member with 
unspecified arthritis. Black and Asian patients did not report 
any family history of rheumatic disease. 
4. AGE AT DISEASE-ONSET. PRESENTATION AND DURATION 
TABLE 6 Age at onset, age at presentation and duration of 








































































The age at symptom-onset was similar across the spondylo-
arthropathy spectrum ( Table 6). Al though the EA group was 
slightly older, the size of the group was too small to permit 
valid comment. The ReA patients were younger than the mean age 
at presentation ( p=O. 018), and had a significantly shorter 
duration of disease (p=0.022). These differences persisted 
even after exclusion of the juvenile-onset sub-group (n=9) from 
the analysis. 
PATI'ERNS OF DISEASE 
The clinical patterns at presentation with spondyloarthritis, as 
studied in 100 patients, are detailed below in terms of: 
spondylitis 
peripheral arthritis 






Poor chest expansion 
!58% 
Schober's test +ve 
i56% 
0 20 40 60 80 
Prevalence (%) 
Figure 5: Clinical features of spondylitis in 
100 spondyloarthropathy patients 
100 
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Approximately 50% of the total cohort had clinical fea
tures 
of spondylitis (Figure 5). Inflammatory back pain accom-
panied by the three clinical signs of advanced spond
ylitis 
were more common in AS when compared to PsA and
 ReA 
(p<0.005) (Figure 6). A small clustering of spondylitis 























Figure 6 Distribution of spondylitis features 
across spondyloarthopathy spectrum 
5.2 Peripheral arthritis 
Figure 7 shows that while spondyli tis prevailed in
 AS, 
peripheral arthritis was dominant in PsA, ReA and 
USpA. 
Overall, therefore, peripheral joint disease was 
more 
common than axial involvement (p<0.005). 
Large joint peripheral arthritis was more common ov
erall 
(p<0.005), and small joint disease was mostly recorde
d in 







AS (35) PsA (35) EA (2) ReA (13) USpA (15) 
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Patterns of j oint involvement across the 






















Mixed joints • large AND small peripheral joints 




5.3 Tenosynovitis and enthesitis 
Tenosynovitis, commonest in PsA and ReA, was present in 












§ -[illillill . 
AS (35) PsA (35) ReA (13) USpA (15) 
1 9 3 
7 3 6 6 
2. 1 
Figure 9 Non-articular musculoskeletal features 
Enthesitis at the insertion of the Achilles tendon or 
plantar fascia insertion was recorded in 25 cases, and 
occurred with similar frequency in AS, ReA and USpA, but 
was less frequent in PsA (Figure 9). 
5.4 Extra-articular manifestations 
Extra-articular features are tabulated in Table 7. Of 
note, acute anterior uveitis (AAU) was more common in AS 
than PsA (p<O. 05), and mucocutaneous features occurred in 
less than one-quarter of ReA patients. 
In reactive arthritis, rheumatological manifestations 
were more often preceded by urethritis ( 9/13) than 
diarrhoea (4/13) (p<0.05). 
35 
TABLE 7 Extra-articular features in spondyloarthritis 
AS PsA ReA USpA 
(n=35) (n=35) (n=13) (n=15) 
Conjunctivitis 2 2 






Aortic 1* 1 
regurgitation 
• 84-year-old patient. Kot investigated to exclude other causes o~ aortic regurgitation . 
6. LATE COMPLICATIONS 
7 . 
Cervical myelopathy was present in one of three PsA cases 
with radiological atlanto-axial cervical spine disease. No 
reports of apical pulmonary fibrosis ( in the absence of 
previous pulmonary tuberculosis), cauda equina syndrome or 
spinal fractures were noted. 
HLA-B27 STATUS 
Tissue typing, specifically for HLA-B27 antigen, was carried 
out in 45 patients, amongst whom 51.1% were positive (Table 8). 




















8. LABORATORY AND RADIOGRAPHIC DATA 
8.1 Rheumatoid factor 
Serological tests for rheumatoid factor were available 
on 51 patients. In only two patients was the result 
positive (4%). These two patients had features con-
sistent with SpA rather than RA: 
(i) a 40-year-old HLA-B27 negative Coloured male with 
AS as evidenced by: peripheral arthritis, spondy-
li tis (inflammatory back pain, limitation of lumbar 
spine motion in three planes, and limited chest 
expansion), radiographic sacroiliitis, and spinal 
radiongraphs showing advanced disease with 'bamboo 
spine' changes. 
(ii) a 34-year-old HLA-B27 positive Coloured male with 
PsA as evidenced by: characteristic skin rash of 
psoriasis, peripheral resorptive arthritis, 
spondylitis (inflammatory back pain and limitation 
of lumbar spine motion in three planes) , radio-
graphic sacroiliitis, and spinal radiographs 
showing evidence of spondylitis. 
8.2 Microbiological evaluation 
Results of relevant serology and/or stool culture were 
recorded in 7 cases. A White patient with ReA had a 
stool culture result positive for Yersinia entero-
colitica. 
8.3 Spinal radiographs 
45 Spinal radiograph reports were recorded across the 
disease spectrum. Radiographic abnormalities were 
reported in 80% (36/45) of available radiographs, and 
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77 .8% ( 28 / 36) of these find i ngs were considered to be 
causally related to the underlying spondyloarthropathy. 
25 
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AA disease LG] 
Spondylitis -
AS (24) PsA (12) EA (2) ReA (1) USpA (6) 
3 
21 2 2 
AA • atlanto-axial disease (n) • number of patients with radiograph reports 
Figure 10 : Spinal radiographic features relevant 
to spondyloarthritis 
Radiographic spondylitis was dominant in AS, of similar 
but reduced prevalence in PsA and USpA, and was not 
reported in EA or ReA. Atlante-axial disease was 
present in three PsA patients only (Figure 10), but neck 
radiographs were not performed routinely in all patients. 
8.4 Sacroiliac joint radiographs 
Radiographic analysis of sacroiliac joint pathology was 
available in 69 cases overall. 60.9% (42/69) of 
radiographs were considered to demonstrate sacroiliitis, 
which was bilateral in 35 cases, and unilateral in the 











AS (32) PsA (15) EA (1) ReA (9) USpA (12) 
SIJ (u) D 5 1 
SIJ (b) - 27 4 1 SIJ • sacroiliac joint (u) • unilateral (b) • bilateral 
(n) • number of atients with rad io ra 
Figure 11 Radiographic sacroiliitis 
8.5 Peripheral joint radiographs 
1 
3 
Radiographic evaluation of the peripheral joints was 
available for 61 cases. 67% (41/61) of reports 
documented abnormal findings in keeping with, though not 
specific for, the underlying type of SpA. Radiographic 
evidence of peripheral joint damage was largely 
restricted to AS and PsA compared with ReA (p<0.005) and 
USpA (p<0.05). As many as 80% of the peripheral joint 
radiographic changes were compatible with advanced 
cartilage damage. Resorptive changes were not common 











AS (15) PsA (27) EA (1) ReA (10) SpA (8 
"Destroyed" joint(s) D 8 2 
Resorptive arthritis D 1 2 
Erosive arthritis - 3 17 1 "Destroyed" joint(s) • advanced post-inflammatory changes 
(n) • number of patients with radiograph reports 
2 
Figure 12 Distribution of radiographic changes 
indicating peripheral joint damage 
MANAGEMENT 
Most patients were managed with drug therapy. 
intervention was uncommon. 
9.1 Medical therapy 
Symptomatic therapy only (analgesia, 
Surgical 
NSAIDs) was 
prescribed for 80 patients, while just 16 patients 
(10 Coloured, 6 White) received disease modifying anti-
rheumatic drugs (DMARD), 11 (69%) of whom had PsA (see 
Table 9). 
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Percentage i ndicated in parentheses 






( 2 . 9 ) 
2 























Weekly oral methotrexate was most commonly used (75% of 
prescriptions), while sulphasalazine was taken by three 
patients, and one patient received parenteral gold 
therapy. This patient, with AS, was also the only 
person in this cohort to have received three courses of 
radiation therapy at disease onset in 1947. 
Data from Table 10 (see overleaf) shows that DMARD use 
was more common in patients with PsA, prolonged disease 
duration and erosive OR resorptive changes on peripheral 
joint radiographs. 
Gender, ethnic origin and HLA-B27 status, as expected, 
were not significantly associated with DMARD use. Sub-
group analysis of age at disease onset in PsA patients 
requiring DMARDs, as compared with those not requiring 
DMARD therapy, showed a tendency towards a younger age 
at disease onset (p=0.054) in those using DMARDs. 
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TABLE 10 Comparison of selected clinical and radio-
graphic features in spondyloarthritis patients 
using DMARDs and/or symptomatic therapy 



















































Antimicrobial therapy was reported to have been used 
(repeated courses of tetracycline) in one case of ReA 
only. 
Chemical synovectomy using mustine was attempted in the 
knees of one PsA patient, with good success. 
9.2 Orthopaedic surgical procedures 
15 Patients underwent a total of 28 orthopaedic 
surgical procedures as outlined in Table 11. More 
than one-quarter (8/28) of all joint arthroplasty 
procedures were performed in three juvenile-onset SpA 
patients (one patient required revision of bilateral 
total hip arthroplasties). 
42 
TABLE 11: Orthopaedic surgical procedures 
AS (n=35) PsA (n=35) 
















3 - unilateral 
TKR 








5 3 5 28 
pts • patients proc • procedure THR • total hip replacement TlCR • to~a l knee replacement MCP • metacarpophalangeal 
Table 12 (see overleaf) shows that large joint arthro-
plasty was more commonly performed in patients who had 
AS, early-onset disease, prolonged disease duration, 
and peripheral joint radiographs showing features of 
'destroyed' joint(s). 
Gender, ethnic origin and HLA-B27 status did not 
influence joint arthroplasty requirements. Since 
almost 30% of large joint arthroplasties were performed 
in juvenile disease-onset patients, analysis of the 
comparison in Table 12 was also performed after 
exclusion of all juvenile disease-onset patients. The 
tendency to prolonged disease duration in arthroplasty 
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patients persisted, but failed to achieve statistical 
significance, while the other findings (except age at 
onset) remained unchanged. 
TABLE 1.2 Selected clinical and radiographic features in 
spondyloarthritis patients requiring arthroplasty 
surgery as compared to patients not requiring 
surgery. 
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II. INFLUENCE OF ETHNICITY ON PATTERNS OF DISEASE 
Data analysis was performed to assess the influence of ethnic 
origin on the overall picture of spondyloarthritis in our cohort 
of 100 patients. The results of detailed analysis are contained 
in Appendix E, (p.95-7) and only the important differences are 
discussed in this section. 
While age of disease-onset and presentation did not differ 
significantly, Table 13 shows 5 Black patients who presented early 
and with relatively short duration of disease. The two Indian 
males were older both at the time of disease-onset and present-
ation, when compared to the mean values of the group as a whole. 
TABLE 13 Age at disease-onset, presentation and duration in 
spondyloarthritis patients of differing ethnic origin 
WHITE 
(n=40) 
Age at onset 32.2 
mean (±SD) (±17.3) 
range (yrs) 10-82 
Age at presentation 40.4 
mean (±SD) (±17.1) 
range (yrs) 13-84 
Disease duration 8.3 
mean (±SD) {±9.8) 
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Patterns of disease in spondyloarthropathy 
patients of varying ethnic origin 
1-----·----_ .. ______ .. 
1------·------------
White (40) Coloured (53) Black (5) Asian (2) 
7 18 3 1 
19 26 1 1 
1 2 
Mixed joints • large AND small peripheral joints 
Figure 14 Peripheral arthritis patterns 
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Analysis of joint disease patterns, according to ethnic 
origin, demonstrates that while spondylitis and peripheral 
arthritis (both large and small joints) were seen with 
similar frequency in Whites, there was a clear excess of 
peripheral arthritis (large joints) in the Coloured patient 
subgroup (p<0.005). There was a similar trend in Black 
patients, but numbers were too few in the Black and Asian 
groups to permit valid comments (refer to Figures 13 and 14). 
Ethnicity was also linked to an increased prevalence of 
enthesitis, as compared to tenosynovitis (p<0.05), observed 
in Coloured ~atients only (Table 14). 
TABLE 14 Non-articular musculoskeletal system features in 



















Triggers to the onset of ReA (urethritis, diarrhoea) were 
also found to vary according to ethnic origin. While 
urethritis (cervicitis in females) preceded all cases of ReA 
in Coloureds, it accounted for only half of the White 
patients, the remainder of whom had diarrhoea prior to the 
onset of rheumatic manifestations. One of two Black 
patients had diarrhoea and the other had urethritis preceding 
the onset of ReA. 
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Peripheral joint radiological features also showed variation 
based on ethnic heterogeneity. Peripheral joint erosive 
changes occurred in eight of nine White patients with 
spondyloarthritis in whom radiological reports were avail-
able. In contrast, only half of Coloured patients (12/24) 
had features of erosive arthropathy on X-rays (Appendix E: 
Tables 20(a) and (b) p.103). 
Advanced changes ('destroyed' joints) were reported in 
Coloured (10/24) and Black (2/4) patients only (Appendix E: 
Tables 20(b) and (c), p.103-4). 
TABLE 15 Large joint arthroplasty surgery performed in patients 
of varying ethnic origin 
Large joint WHITE COLOURED BLACK ASIAN 
No. 
No. 
arthroplasty (n=40) (n=53) (n=5) (n=2) 
of patients 3 10 1 
of procedures 6 20 1 
Of 27 large joint arthroplasties performed in 14 patients, 
74% of procedures were performed in Coloured patients, while 
the remaining seven procedures were performed in three Whites 
and one Black patient (p<O. 005). Despite the increased 
number of Coloureds requiring arthroplasty, ethnic origin per 
se did not influence joint replacement surgery requirements 






DMARD use and arthroplasty surgery performed in 
in spondyloarthritis patients of differing ethnic 
origin 
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NO DMARD USE 
(n=84) 














3 (21.4) 37 (43.5) 
10 ( 71. 4) 42 (49.4) 
1 (7) 4 (4.7) 
2 ( 2 . 3 ) 
Percentage i ndicated i n parentheses 
• Large j oint arthroplasty only 
Similarly, Table 16 also shows that Coloured patients 
accounted for 62.5% of DMARD use, but race per se was not 
significantly associated with DMARD use (p-value not 
significant) . 
Also, the clinical and radiographic features of spondylitis, 
prevalence of radiographic sacroiliitis, extra-articular 
manifestations and HLA-B27 prevalence were not influenced by 
ethnicity (refer to Appendix E: Tables 17 - 20(c) p.102-4). 
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III. INFLUENCE OF GENDER ON PATTERNS OF DISEASE 
The influence of gender on disease patterns in spondyloarthritis 
patients was evaluated in the 100 cases studied. All the data 
reviewed is contained in Appendix F (p.105-8), and only important 
differences are highlighted in this section. 
Females had a notably later age of disease-onset and presentation, 
the mean age for females exceeding that of males by ten years or 
more. This was true of all disease subgroups except USpA, where 
age of disease-onset was similar in males and females (refer to 
Table 21 and Figure 15). 
TABLE 21 Gender-based differences in 100 spondylo-











Age at onset* 
mean (±SD) (yrs) 
range 
Age of presentation** 
mean (±SD) (yrs) 
range 
Disease duration 










Age at onset 
(years) 
Mean age + 1SD 
Mean age - 1SD 
Mean age 
50 
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40 - ... · 
~ 
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AS PsA l ReA I IUSpA I 
0 
F M F M F M F M 
I 61 39.5 64.6 42.4 60.2 34.4 37.2 36.1 
I 12.6 14.5 25.2 15.6 24.8 19.6 18.4 19.9 
+ 36.8 27 44.9 29 42.5 27 27.7 28 
F • females M • males 
Figure 15 Comparison of age of disease-onset in males and 
females of different spondyloarthropathy disease 
subgroups 
While the overall pattern of joint disease did not differ 
signif i cantly in males and females (Appendix F: Figure 16, p.105), 
i t was observed that inflammatory back pain was more common in 
males (Table 22(a)). Disease-based subgroup comparison (Table 
22(b)) showed that the increased prevalence of spondylitis 
observed in males was restricted to PsA patients. 
No other features regarding non-articular musculoskeletal system 
f eatures, extra-articular features, HLA-B27 prevalence, radio-
graphic data including sacroiliitis, or large joint arthroplasty 
requirements differed significantly on the basis of gender (refer 
t o Appendix F: Tables 23-27 and Figures 16 and 17, p . 105-8). 
TABLE 22(a) Clinical features of spondylitis 
MALES 
(n=71) 
45/71 Inflammatory back 
(63.4) pain* 
34/69 Reduced spinal 
(49.3) mobility 
26/44 Reduced chest 
(59.1) expansion 
30/53 Schober's test 
(56.6) positive 
Denominator • number ot patients i n whom presence/ absence ot f eature was recorded 
• p<0.005 











TABLE 22(b) Comparison of selected clinical features of 


















IV. INFLUENCE OF HLA-B27 ON PATTERNS OF DISEASE 
Comparison of spondyloarthritis patients on the basis .of HLA-B27 
status was performed so as to evaluate the influence of this 
genetically-determined variable. 
TABLE 28 . Demographic data for spondyloarthritis patients . 
according to HLA-B27 status 
HLA-B27 +ve HLA-B27 -ve 
(n=23) (n=22) 
AS PsA ReA USpA AS PsA ReA USpA 
Black 
1 (n=2) 1 
White 
4 3 3(1) (n=21) 5 3(2) 3(1) 
Coloured 
7(1) 1 3 (1) (n=22) 2 3(1) 1 4(1) 
12(1) 1 6 4(2) TOTAL 8 6(3) 1 7(2) 
6.7:1 overall male:female ratio 3.4:1 
(n ) • nmobar ot r-1• in qroup 
# 
The demographic data of 45 patients whose HLA-B27 status was 
known, is seen in Table 28. AS (60%) and ReA (85.7%) cases were 
strongly associated with the HLA-B27 antigen, whilst the majority 
of patients with PsA (85.7%) were HLA-B27 negative; less than 
half of patients with USpA (36.4%) were HLA-B27 antigen positive. 















Age at disease-onset 
mean (±SD), range (yrs) 
Age at presentation 
mean (±SD), range (yrs) 
Clinical spondylitis: * 
- inflammatory back pain 
- reduced spinal mobility 
- reduced chest expansion 
- Schober's test positive 
Radiographic spondylitis * 
Anterior uveitis 
Diarrhoea 














In patients with spondyloarthritis, the presence of the HLA-B27 
antigen was associated with an earlier age of disease-onset 
(p=0.03) and a tendency towards earlier presentation, and proved 
predictive of clinical but, more especially, of radiographic 
spondylitis (p<0.01), and of anterior uveitis as an extra-
articular feature (Table 29). 
As most cases of ReA were HLA-B27 carriers, triggers to the 
disease in this category (diarrhoea, urethritis) were linked to 
positive HLA-B27 status (Table 29). 
Conversely, HLA-B2 7 negativity ( majority of PsA patients) was 


























Figure 18: Patterns of peripheral joint disease in 
spondyloarthritis patients of differing 
HLA-B27 status 
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In view of data relating to HLA-B27-based comparisons in spondylo-
arthri tis ( refer to Chapter One: Introduction and Literature 
Review, p.6-7), a separate analysis of AS was performed. 
As shown in Table 30, carriage of the HLA-B27 antigen in AS 
patients had only a modest influence on the ~ge of disease-onset 
(p-value not significant), and was predictive of anterior uveitis 
as an extra-articular manifestation. 
TABLE 30: A comparison of selected features in AS patients 






Age of disease-onset 







In contrast to the findings with regard to spondyloarthropathy in 
general, in AS patients the clinical and radiographic features of 
spondylitis did not differ in relation to HLA-B27 status 
(Appendix G: Tables 31-32(b), p.109-110). 
Finally, ·neither the prevalence of radiographic sacroiliitis, nor 
peripheral joint radiographic findings nor the ultimate management 
of patients appeared to be influenced by HLA-B27 status (refer to 





Discussion of this study focuses on four distinct aspects of the 
results, and addresses each in turn. 
1. spondyloarthropathies are uncOllllllon in Black south Africans. 
The reduced prevalence of SpA in South African Blacks, as 
seen in Black communities elsewhere in Africa, is discussed, 
and possible reasons for this finding are explored. 
2 • The clinical picture of sponctyloarthritis in urban south 
Africans. 
3. 
The broad clinical spectrum of spondyloarthritis, as 
documented in this report of urban South Africans, is 
compared with published international data. The striking 
overall similarities are highlighted, and potential 
explanations for observed differences a~e offered. Also, 
the influences of ethnicity, gender and HLA-B27 are examined 
in the light of existing data. 
The management of sponctyloarthropa.thies in a south African 
university-based Rheumatic Diseases unit. 
The pharmacological and surgical management options utilised 
by the RDU, UCT largely reflect international trends and this 
is discussed in some detail. 
4. 
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Explanations accounting for the apparent increased prevalence 
of joint arthroplasty locally are examined. 
Why the paucity of reactive arthritis? 
The striking paucity of reactive arthritis in a developing 
African country such as South Africa, where urethritis and 
diarrhoea are common clinical problems, is highlighted and 
theoretical explanations for this phenomenon proposed. 
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1. SPONDYLOARTHROPATHIES ARE UNCOMMON IN BLACK SOUTH AFRICANS 
This study, and other similar reports, indicate that up to 7% 
of African patients, presenting with rheumatic disease-
related symptoms, have spondyloarthritis (SpA) (Table 34). 
TABLE 34 Prevalence of spondyloarthritis in Africa 
SpA prevalence (%)* 
Zimbabwe, 1990 







· 6 months, prospective 
· Blacks, n=141 
· 10 months, prospective 
• Blacks, n=411 
· 27 months, retrospective 
· Blacks, n=2020 
· 72 months, retrospective 
• Multi-racial, n=1925 







•• Study i ncluded patients known to the hospital - not representative of preval ence of spondyloarthritis 
in a •New Patient• clinic 






including progressive unexplained loss of weight, chronic unexplained dia~~oea, peripheral lymphadonopathy, 
oral candidiasis or oral hairy leukoplakia. 
Despite the crude nature of these prevalence data, the 
presence of SpA in Africa is confirmed, and the, until 
recently, under-estimated burden of rheumatic disease on this 
continent highlighted (57,92). 
There is a striking paucity of Black patients in this South 
African study, in spite of White, Coloured and Asian patient 
numbers being fairly representative of both the population 
residing in the Cape Peninsula and those attending State-
funded hospital OPDs in the region (Table 35). 
TABLE 35: Ethnic composition of the resident population, and 
State-funded hospital OPD attendance, in the Cape 
Peninsula - 1991 
Resident Hospital OPDs (%) Cape Town 
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Population (%) SpA study ( % ) 
(81) (82)* 
White 25.9 13.1 
Coloured 50.7 65.4** 
Black 22 21.5 
Asian 1.4 0.3*** 
TOTAL NUMBER 1 869 145 1 589 595 
• Av.rage calC\llat.d tree 1919/90 and lttO/tl data 
•• COllpoaita tiqura tor coloured and Asian - •eparata •tat1•t1c• poorly O•t1ned (Ill 






Indeed, White patients comprised a greater than expected pro-
portion of the cohort, probably reflecting the increased 
prevalence of HLA-B27-associated disorders in an ethnic group 
having a significantly higher background prevalence of HLA-
B27 when compared with other South African ethnic groups ., 
(refer to Chapter One: Introduction and literature review -
Table 1, p.13). Also, the increased use of State-funded, 
and university-linked, rheumatological services by more 
affluent sectors of the community, consequent upon the 
limited availability of such expertise nationally (93), may 
have contributed an element of referral bias. 
Although the size of the Coloured patient cohort of this 
study was proportional to the population composition of the 
Cape Peninsula in the early 1990s, it may constitute a 
relative over-representation, given the reduced background 
prevalence of HLA-B27 in Coloured when compared to White 
South Africans (refer to Chapter One: Introduction and 
literature review - Table 1, p.13). 
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This may be due to referral bias, since PAOH is situated in 
close proximity to a former 'Coloured housing zone'. 
However, good transport facilities by both road and rail from 
all areas of the Cape Peninsula, and the referral nature of 
the hospital services are likely to have largely protected 
the data from major influence from this potential confounding 
variable. 
National population statistics indicate that, during the time 
period of this study, 78% of Asians were resident in Natal 
( including KwaZulu) , while only 4. 6% stayed in the Cape 
Province (Western and Eastern regions) (94). Differential 
geographical distribution therefore accounts for the small 
minority of Asian patients in this study. 
In contrast, Black people constituted at least 22% of the 
resident Cape Peninsula population in 1991 (refer to Chapter 
Two: Study Design and Methods Figure 2b, p. 21) , and 
represented 21.5% of patients attending State-funded hospital 
OPDs at that time (refer to Chapter Two: Study Design and 
Methods - Table 3, p.22). In the light.of these data it is 
improbable that the reduced number of Black SpA patients 
observed can be attributed to financial or geographical 
constraints. Rather, this pattern is compatible with a 
truly diminished prevalence of HLA-B27-associated SpA in 
Black South Africans. 
It is recognised that health service-based data collection, 
particularly in developing countries, is fraught with 
difficulty (important factors listed in Table 36) and, in its 
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turn, is liable to create false impressions of actual disease 
prevalence. While such influences are relevant to this 
study, they do not entirely explain the demographic 
phenomenon observed; other factors such as genetic make-up, 
environmental influences and host immune responses need to be 
considered. 
text. 
These will be amplified in the subsequent 
TABLE 36: Factors influencing public health service-based data 
collection 
* Limited/inaccessible health care facilities 
* Inadequate primary health care evaluation 
* Restricted access to specialist opinion/care 
* Budget restrictions curtailing use of extensive 
and/or expensive diagnostic investigations 
., 
The prevalence of SpA correlates in a positive manner with 
the background prevalence of HLA-B27 in the specific 
population group being considered (27 quoted in 5, 28, 32). 
Hence the scarcity of this HLA haplotype in African Blacks 
(Table 37) should account for the virtual absence of Blacks 
in this SpA study cohort. However, fewer than 50% of 
recorded SpA cases are HLA-B27-associated in communities 
having a reduced background HLA-B27 prevalence (Table 37). 
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TABLE 37: HLA-B27 prevalence in populations of Black African 
descent 
HLA-B27 prevalence(%) 
American Blacks (32, 95*) 
Zimbabwean Blacks (63, 67) 
South African Blacks 
(61, 63, 68) 









Also, recent data from The Gambia demonstrate that, despite 
a local HLA-B27 prevalence figure of 6% (96) resembling the 
8% prevalence in White North European communities ( 27 , .. quoted 
in ( 5)) , no case of SpA was detected in 1115 subjects 
examined (96). This finding has previously been attributed 
to regional dominance (in West Africa) of the HLA-B*2703 
subtype which, of nine recognised B27 allotypes ( 35), is 
thought not to be associated with SpA (97). However, Brown 
et al have shown that whilst 50% of HLA-B27 positive Gambian 
subjects (without AS) were subtype B*2703 positive, the 
remainder were B*2705 positive (96). This is an unexpected 
finding since the B*2705 allotype commonly occurs in SpA 
patients of White North European population groups (35) . 
• 
Thus it is clear that HLA-B27 antigen status is not the only 
important factor in the pathogenesis of SpA (32, 34, 36, 45), 
and ongoing research is needed to identify additional protec-
tive factors accounting for the diminished prevalence of SpA 
in selected population groups, locally and elsewhere. 
Currently, additional HLA class I and II alleles, which 
appear to be relevant to the development of SpA, AS and ReA 
in particular, have been identified (98, 99). However, such 
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preliminary data, of additional genetically-mediated 
influences, require better definition before it is possible 
to implicate that the absence of such genetic factors is able 
to confer protection against onset of SpA in identified 
ethnic groups. 
2. THE CLINICAL PICTURE OF SpA IN SOUTH AFRICANS 
The SpA disease spectrum, as recorded in South Africans in 
this study, is concordant with that described in the 
international rheumatology literature. Comparison of Tables 
38 and 39 confirm the similarities, and highlight several 
interesting points. 
TABLE 38 Clinical patterns of disease in 100 spondyloarthritis 
patients studied in Cape Town (1988-1994) 
AS PsA EA ReA USpA 
(n=35) (n=35) (n=2) (n=13) (n=15) 
Age at onset, mean 29 35 42 29 28 
(range) (yrs) (13-82) (10-74) (32-53) (17-55) (13-40) 
Gender 
males:females 4.8:1 1.5:1 1:1 5.5:1 1.5:1 
Prevalence (%) 
Spondylitis 100 51 50 8 33 
Peripheral arthritis 54 94 50 100 87 
Sacroiliitis 100 33 100 33 
Enthesitis 20 14 46 47 
Tenosynovitis 3 31 23 7 
Uveitis 17 3 
Aortic regurgitation 3 7 
HLA-B27 positive 60 14 86 36 
TABLE 39: Clinical patterns of disease in spondyloarthritis -
international data 














PA • peripheral art:hritia 
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The wide range of age at disease-onset in South African 
SpA patients, is accounted for by the inclusion of 9 
cases with juvenile-onset .disease and three AS patients 
with disease-onset beyond 50 years.of age. Although 
late-onset AS is uncommon, this has been well documented 
in a French case series of ten males (121), and was also 
recorded in four of eight African Blacks with AS, as 
reported by Chalmers {61). 
Figure 19 demonstrates the shift in emphasis with 
respect to articular features that occurs across the SpA 
spectrum; AS prevails at the spondylitis end of the 
spectrum, progressing through PsA, USpA and ReA toward 
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the peripheral arthritis end of the spectrum. Data 
from Table 39 confirms that this pattern is also 
observed internationally. Understanding SpA in terms of 
a broad spectrum, with varying emphasis on axial or 
peripheral manifestations, is in line with the current 
trend of broadening the overall disease concept and 
thereby accommodating patients previously excluded by 








AS PsA USpA ReA 
Periph. arthritis - 54 94 87 100 Spondylitis D 100 51 33 8 
Figure 19: The spondyloarthropathy disease spectrum 
- The local prevalence of spondylitis in PsA cases was 
greater than usually reported elsewhere (109, 110, 113). 
However, this figure does vary in the literature, as 
illustrated by a previous study conducted by the RDU 
(OCT), in which spondylitis was reported in 88% of 
psoriasis patients with arthritis (77). 
66 
In this study both spondylitis and sacroiliitis were 
more frequently recorded in USpA cases than is generally 
quoted in the literature (107, 120). However, reports 
regarding this subset of SpA are few, and the clinical 
picture is still emerging. 
would thus be premature. 
Explanations at this point 
An alarming number of PsA patients (70.4%) were noted to 
have radiographic evidence of erosive, deforming 
arthritis in the Cape Town data. Recent studies are 
however highlighting the aggressive nature of PsA, 
reporting erosive, deforming radiographic changes in up 
to 57% of series (77, 109, 110) • 
• 'Destroyed' peripheral joints indicating advan9ed post-
inflammatory features (obliteration of the joint space 
with/without ankylosis of the joint) were recorded in 
53% of AS patients for whom radiograph reports were 
available. These patients generally required large 
joint arthroplasty procedures. Possible explanations 
for this observation are discussed •in detail later • 
• An unusually high percentage of bilateral sacroiliitis 
was observed in the PsA subset of local SpA patients. 
In general, this feature is largely restricted to HLA-
B27 positive PsA subjects (about 85% of cases), in which 
circumstance more than half have bilateral sacroiliac 
changes (110). While the only HLA-B27 positive patient 
in this study had bilateral sacroiliitis, HLA typing was 
not available for the remaining four PsA patients with 
bilateral sacroiliitis. 
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Conclusions regarding this 
feature of the study are thus limited. 
TABLE 40: Variations in spondyloarthritis disease patterns as 
determined by selected genetic variables 
ETHNIC ORIGIN 
tendency to present earlier; shorter disease 
duration (B) 
peripheral arthritis more common than spondylitis (C) 
peripheral joint radiographs : 
- erosive changes (W) 
- erosive changes and 'destroyed' joints (C) 
74% of arthroplasties (C) 
GENDER 
delayed age of onset (f) 
increased prevalence of back pain (m) 
HLA-B27 STATUS 
- earlier age of onset(+) 
increased prevalence of: 
- spondylitis (+) 
- small joint peripheral arthritis(-) 
- anterior uveitis (+) 
(Bl - Blacl<a, (W) - llbitea, (C) - COloureda 
Ct)• faaalu, (•l • aa1 .. 
(+) • BLA-827 posit!.,., (-) • BLA-B27 nevatiYa 
The influence of selected, genetically-determined 
variables on the SpA disease profile observed in this 
• 
study, are highlighted in Table 40. 
interesting observations are made: 
Several 
The small cohort of Black patients reported in this 
study did not present with advanced, neglected 
longstanding disease, supporting the concept that 
delayed and/or limited access to health care facilities 
were not significant factors accounting for their under-
representation in this study. 
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It is surprising that, despite a probable element of 
referral bias accounting for both White and Coloured 
patient numbers in this RDU study (as discussed earlier 
in this chapter), the excess of peripheral arthritis, 
particularly advanced disease requiring arthroplasty, 
was observed predominantly in Coloured patients. 
Al though this may suggest that aggressive peripheral 
joint disease in SpA is more common in Coloured South 
Africans, a statement such as this could only be made 
with any measure of confidence after review "' Of all 
arthroplasties performed in SpA patients in both State-
funded and private local medical facilities. such co-
ordinated data collection is not available, and thus 
interpretation of this observation is limited. 
- The delayed onset of SpA observed in females (p=0.006) 
requires careful consideration. Disease-based subgroup 
analysis shows that the overall trend to delayed onset 
was only significant in the PsA subgroup (p=0.015), 
while small sample size in the other subgroups precluded , 
useful comparison. Since the onset of arthritis in 
psoriasis occurs across a wide age range, approximately 
8-80 years ( 77, 109), the delayed disease-onset in 
females, as recorded in this study, may represent a non-
specific finding. 
- Back pain and restricted spinal mobility, two features 
of spondylitis, were more frequently recorded in males, 
specifically of the PsA subgroup. This observation has 
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been recorded elsewhere ( 109, 110, 112), and Torre 
Alonso, et al (110) have shown that the spondylitic form 
of PsA, predominant in males, is associated with 
increased levels of immunoglobulin A (IgA), suggesting 
a possible relationship between AS and psoriatic 
spondylitis. While a similar clinical finding is 
reflected in this study, IgA levels were not studied. 
HLA-B27 positivity, in this study, was associated with 
early age of disease-onset, spondylitis and anterior 
uveitis. Review restricted to the AS subgroup shows 
that only the prevalence of anterior uveitis varies with 
HLA-B27 status. This matter has been intensely debated 
in the literature, and was discussed earlier (Chapter 
One: Introduction and literature review; - 2. ·• The HLA-
B27 Association, p.5-7). It transpires that differ-
ences in clinical disease profiles, incorrectly ascribed 
to HLA-B27 status, merely reflect the heterogenous 
nature of the various disorders constituting the SpA 
spectrum (30). 
• 
- The association of small joint disease and HLA-B27 
negativity reported in this study, is easily explained 
by the observation that small joint involvement featured 
prominently in PsA cases, most of whom were HLA-B27 
negative (85%). 
Based on the observations of this descriptive study, 
therefore, the conclusion is that SpA disease patterns in 
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urban South Africans largely reflect those seen in Europe and 
North America. This is consistent with observations in 
Southern Africa relating to other rheumatic diseases, such as 
rheumatoid arthritis (RA) ; urbanised Africans display RA 
disease patterns similar to those described in First World 
centres (122). 
3 • THE MANAGEMENT OF SPONDYLOARTHR,ITIS IN A SOOTH AFRICAN 
UNIVERSITY-BASED RHEUMATIC DISEASES UNIT 
Therapeutic management strategies utilised by the RDU (UCT) 
in the management of SpA are summarised in Table 41. 
TABLE 41 . Management of Spondyloarthritis, RDU, Cape Town . 
Prevalence (%) 
AS PsA EA ReA USpA 
(n=35) (n=35) (n=2) (n=l3) (n=l5) 
Symptomatic therapy 
only 83 69 50 85 100 
DMARD 11 31 
Corticosteroid 9 3 , 
Large joint arthroplasty 26 8 
Symptomatic treatments (analgesics and NSAIDs) were 
prescribed in the majority of patients, reflecting the 
internationally recognised efficacy of these agents in relief 
of symptoms in SpA patients (123). 
Similarly, DMARD use in the RDU (Cape Town) also reflects 
international trends, where most experience exists in the use 
20 
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of sulphasalazine in AS and methotrexate in PsA (cumulative 
data summarised in (123) and (124)). 
The high prevalence of erosive, deforming arthritis observed 
in this series of PsA patients (70.4%) and similar data from 
other centres (77, 109, 110), together with reports of severe 
functional impairment (American Rheumatology Association 
Class III-IV) in up to 19% of cases (109, 110), more than 
justifies the use of DMARDs in PsA patients locally and 
abroad (109). Based on current observations, earlier, more 
aggressive use of DMARDs is being advocated in an attempt to 
alter the unfavourable outcome of PsA in a significant 
percentage of cases (109, 110). 
Methotrexate (low-dose oral weekly therapy) was the DMARD of 
choice in the management of PsA in this study. Therapeutic 
efficacy of this agent was first demonstrated in a 
parenterally administered double-blind placebo-controlled 
trial in 1964 (125), and subsequently low-dose oral therapy 
has been shown to be of variable benefit (43-80%) in small 
• 
open trials and retrospective reports, as reviewed by 
Creemers et al (124). More recently, a multicentre trial 
using low-dose ( 7. 5-15 mg) oral weekly therapy showed a 
favourable response, although the difference failed to 
achieve statistical significance (126). While methotrexate 
is currently the favoured agent, positive reports on the use 
of azathioprine and cyclosporin A are also appearing in the 
literature (127). 
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Sulphasalazine use was restricted to AS and EA patients in 
this study. While the benefit of this agent in the manage-
ment of IBD and related SpA has been previously documented 
(10), meta-analysis of five randomised double-blind placebo-
controlled studies has also demonstrated efficacy and safety 
in the short term (three to six months) use of sulphasalazine 
in AS (128). Despite achieving only modest benefit, largely 
due to extended disease duration prior to the use of 
sulphasalazine in a significant number of cases (129), data 
such as this may promote earlier use of DMARDs in AS too. 
Furthermore, preliminary data suggesting efficacy of other 
DMARDs, including methotrexate, azathioprine and cyclophos-
phamide (124) may soon broaden the spectrum of therapeutic 
options in SpA. 
•\ 
The role of corticosteroids remains questionable, and limited 
use (<10%) in this study probably reflects this uncertainty. 
While data suggesting benefit from short course pulse methyl-
prednisone in acute severe attacks of AS exists ( 130), 
chronic long-term use of oral corticosteroids is generally 
• 
not recommended in AS (123) or PsA (127). 
Radiation therapy, administered to only one patient in the 
study cohort, was abandoned in the 1960s (despite efficacy) 
owing to the associated increased risk of malignancy 
[reviewed in (123) and (124)]. 
TABLE 42: Prevalence of large joint arthroplasty in AS 
patients - international data 
Khan, et al (33) 
Calin, et al (131) 
McKenna, et al (132) 
Wordsworth, et al (133) 
(nl • •1•• or cohort studied) 
• patients rroa National Anl<ylosing Spondyliti• society (NASS) 








Large joint arthroplasty was performed in 14% of the Cape 
Town SpA cohort. The commonest indication for joint 
replacement was a radiographically 'destroyed' joint 
(obliterated joint space with varying degrees of joint 
ankylosis) accompanied by disability. Table 41 indicates 
that one-quarter of all the AS patients studied required 
total hip replacement (THR), while data from Europe and North 
America suggest that only 6-8% of AS cases require THR (Table 
42). However, it is internationally recognised that joint 
arthroplasty procedures are more frequently required in 
juvenile-onset AS (17%) as compared with*adult-onset AS (4%) 
(134). Thus the fact that one-third (6/18) of all total hip 
arthroplasties in AS patients were performed in two juvenile 
disease-onset patients, partly accounts for the apparently 
increased frequency of arthroplasty surgery in AS patients in 
this study. An element of bias is, however, also relevant, 
and is addressed in the subsequent text. 
Since the data in Table 42 are derived from hospital-based 
records (except where indicated), selection bias owing to the 
74 
hospital-based nature of the Cape Town data does not appear 
to account for the observed difference. Furthermore, the 
data of Calin et al (131), gathered by administering a self-
answered postal questionnaire to members of the National 
Ankylosing Spondylitis Society (NASS), demonstrate that even 
community-based surveys provide similar prevalence data 
(large joint arthroplasty) when compared with hospital-based 
studies. 
In the Western Cape, restriction of State-funded surgical 
expertise to two regional centres only, resulting in 
aggregation of selected patients at these centres, is a more 
tenable explanation for the difference between local and 
international data. In Europe and North America, in 
contrast, greater numbers of centres manage such patients, 
tending to spread the surgical load, rather than 'clustering 
patients' at one or two centres, as is the situation locally. 
Similarly, the arthroplasty requirements of PsA and USpA 
patients in this study are subject to the potential "patient 
• 
clustering" phenomenon previously described. However, the 
20% prevalence of large joint prostheses in USpA patients 
studied in Cape Town, has not been noted in other studies of 
this disease subgroup to date. Such data requires further 
evaluation in other centres to confirm this unexpected high 
morbidity figure, in a previously 'ignored' patient 
population. Follow-up data suggesting that a significant 
percentage of USpA go on to develop classical AS over a 
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period of several years (16), tends to support the credi-
bili ty of the observation made in this study. It seems 
plausible that an otherwise previously undefined cohort of 
young patients with neglected large joint (predominantly hip) 
disease, may present for the first time when requiring 
arthroplasty surgery. 
TABLE 43 : Disease profile of AS/PsA patients 
prescribed DMARDs and/or requiring 
large joint arthroplasty 
RDU, Cape Town 
-
-
Early age of onset 
Prolonged disease-duration 
Radiographic joint damage 
•I 
Table 43 reflects the disease profile of high-risk SpA 
patients, as identified in this observational study. Early 
identification of such SpA patients, prior to the development 
of advanced clinical and radiographic joint damage, would 
afford clinicians the opportunity of instituting DMARD 
management earlier, thereby permitting better evaluation of 
the disease-modifying (retarding) efficacy of the various 
agents. Ultimately, this should achieve a reduction in 
arthroplasty requirements, and preserve patients' financial 
and physical independence. The personal and national 
benefits are obvious, especially in a developing country such 
as South Africa. 
Encouraging 'early referral of all cases of synovi tis' 
identified by South African primary health care facilities to 
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a regional RDU referral centre has potential to detect at-
risk patients early, allowing for more effective management 
and a potentially better outcome. Most referred cases would 
ultimately have RA, but SpA patients would certainly form 
part of the referred cohort (approximately 5% according to 
this study) with the potential for similar benefit as in RA. 
In the broader vision of future health care in South Africa, 
including widely accessible primary care facilities, 
encouraging early referral and intervention has the potential 
to improve the long-term outcome of rheumatic disease in an 
African country enormously privileged to have specialist 
rheumatology services. An "Early Synovi tis Clinic" has 
recently been established by the RDU (Cape Town), but large 
scale community awareness and education is required for such 
a facility to demonstrate benefit in the long-term. ·· Hence, 
education of primary medical care-givers (for example, nurse 
practitioners) in the recognition of symptoms and signs of 
rheumatic-related diseases should currently be given 
priority. 
A limited programme geared to training nursing professionals 
in the recognition and limited management (treatment, follow-
up and monitoring of DMARD-related toxicity) of rheumatic 
diseases has been established in the Western Cape under the 
auspices of the Nursing Education Di vision, GSH. Such 
programmes should enjoy wide publicity and support, 
especially from the local rheumatology fraternity, since they 
have potential to impact on the quality of accessible health 
care in the wider community of South Africa. 
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4 • WHY THE PAUCITY OF REACTIVE ARTHRITIS? 
The striking discrepancy between the observed prevalence of ReA, 
and the plethora of potential precipitating infections on the 
African continent, a recent focus of attention (57), is the most 
interesting observation recorded in this study. If ReA is 
expected to occur in 1-3% (20% if HLA-B27 positive) of individ-
uals presenting with urogenital tract or enteric infections known 
to trigger rheumatic manifestations (12), then the number of cases 
reported from Africa is astonishingly low (Table 44). 
TABLE 44 Prevalence of ReA in Africans presenting with 
rheumatic-type symptoms 
Zimbabwe, 1990 (66) 
Zimbabwe, 1991 {68) 
Togo, 1993 (70) 
South Africa, 1994 
• BIV ....,.1:1 .. aubjlOC'U only 






In the metropolitan area of Cape Town alone, approximately 33 
000 people attended municipal Sexually Transmitted Diseases 
(STD) Clinics in 1993 (135). More than 50% of patients were 
new cases (approximately 15/1000 population incidence rate), 
and less than one-third of reported sexual contacts were 
treated ( 135). Non-gonococcal urethritis, most commonly 
Chlamydia trachomatis-related (136), represented more than 
half of cases treated, whilst gonococcal disease (co-
infection with Chlamydia trachomatis in 15-50% (136, 137)) 
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constituted the majority of the remainder. Municipal clinic 
data underestimate the true size of the infected population 
by a considerable margin, but even these conservative figures 
make it very difficult to account for only thirteen new cases 
of ReA seen by the RDU (UCT) over seven years, whilst in 
excess of 100 ooo new cases of STD (Chlamydia trachomatis-
related in the majority) were treated in Cape Town in the 
same time period (135). This hypothetical estimate of the 
local 'population at risk' for ReA does not even take into 
account the prevalence of common ReA-precipitating enteric 
infections, Salmonella and Shigella species in particular; 
such data would merely underscore the already glaring 
hundredfold disparity between the predicted and observed 
data. 
While inaccuracies of health service-based data collection 
(previously outlined in Table 36), incomplete data capture 
owing to the retrospective nature of this study, and the 
diminished prevalence of HLA-B27 in non-White South Africans 
may partly account for the above observation, other relevant 
factors should also be considered. 
Indeed, recent observations in the Gambia by Brown et al (96) 
(refer to Chapter Four: Spondyloarthropathies are uncommon in 
Black South Africans, p.62), have led to speculation that 
genetic (HLA-B27 heterogeneity or non-HLA-B27) or environ-
mental factors may act to protect certain populations from 
the development of SpA-related disorders. Therefore it 
seems reasonable to suggest that diverse environmental 
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microbial antigen exposure may influence the genetically-
determined, immune-mediated human response in circumstances 
of pathogenic antigen challenge, thereby favourably 
modulating the clinical consequences of such microbial 
encounters. In support of this suggestion it has been shown 
in a murine model that vaccination with mycobacterial 65kDa 
heat shock protein (hsp), prior to Mycobacterium tuberculosis 
exposure, protects against the development of adjuvant 
arthritis (138). Heat shock proteins, such as those used in 
this study, are phylogenetically highly conserved potentially 
immunogenic proteins in prokaryotes and eukaryotes (139), and 
are consequently eminently suitable candidate antigens to 
mediate cross-reactive immune responses between unrelated 
microbial pathogens. Furthermore, since Mycobacterium 
tuberculosis, responsible for an estimated 90 million cases 
of tuberculosis in the final decade of this century (140), is 
the most important single pathogen known to man, its hsp is 
an ideal antigen to consider, and further explore, in the 
clinical setting. While mycobacterial hsp has more commonly 
been considered to cross-react with human 60kDa hsp (both 
members of the hsp60 family), thereby implicated in the 
pathogenesis of auto-immune-mediated diseases such as RA 
( 141, 142) , this has not been a consistent experimental 
finding ( 143-145). Alternatively, it is tempting to 
suggest that mycobacterial hsp encountered in the form of 
Mycobacterium bovis Bacillus Calmette Guerin (BCG) 
vaccination and environmental or disease-related exposure may 
promote a protective host immune response upon exposure to 
other pathogens producing antigenically similar hsps. Such 
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influences on immune responses may be particularly relevant 
in areas of the world where tuberculosis has reached epidemic 
proportions, including South Africa where the current annual 
incidence rate for new cases of tuberculosis in Cape Town is 
of the order of 500-800/100 000 population in local Coloured 
and Black communities respectively (146). 
Chlamydia trachomatis, already identified in preceding 
discussion as a major South African pathogen in the STD 
setting, also produces a 60kDa hsp; thus it seems plausible 
that a cross-reactive hsp60-specific memory T-cell-based 
immune response promoting rapid and efficient containment of 
chlamydia! organisms at their portal of entry (urethra or 
cervix) may prevent haematogenous dissemination to peripheral 
joint, and so account for the limited prevalence of ReA 
within a vast pool of people in whom it is known precipi-
tating infections for ReA are common. 




CONCLUSIONS .AND RECOMMENDATIONS 
CONCLUSIONS 
1. The spectrum of spondyloarthropathy at the University of Cape 
Town represents the world-wide experience with respect to 
demography, clinical features, radiography, therapeutic 
requirements and the need for arthroplasty. 
2. Spondyloarthritis is uncommon in Blacks for reasons that are 
not fully explained. 
3. Reactive arthritis is rare in relation to the frequency of 
sexually transmitted diseases in the Cape Peninsula. 
RECOMMEHDATIOHS 
1. Future prospective studies are needed to see the long-term 
outcome of undifferentiated spondyloarthropathy in South 
African patients. 
2. The paucity of spondyloarthri tis in Blacks may hold some 
clues about the pathogenesis of this group of diseases, and 
this merits further study. 
3. Molecular studies, focusing on mycobacterial and related heat 
shock proteins, may elucidate some reasons for reactive 
arthritis being uncommon in our cohort of patients. 
APPENDIX A 
DISEASE CLASSIFICATION CRITERIA AND/OR DEFINITIONS 
1. ANKYLQSING SPONDYLITIS (adapted from 5) 
1.1 Rome, 1961 (6) 
Clinical criteria 
1. Lower back pain and stiffness (more than three months), 
not relieved by rest. 
2. Pain and stiffness in the thoracic region. 
3. Limited motion in the lumbar region. 
4. Limited chest expansion. 
5. History or evidence of iritis or its sequele. 
Radiologic criterion 
6. Radiographs showing bilateral sacroiliac changes 
characteristic of ankylosing spondylitis (this would 
exclude bilateral sacroiliac joint osteoarthritis). 
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Definite ankylosing spondylitis defined by grade 3-4 bilateral 
sacroiliitis and at least one clinical criterion OR at least 
four clinical criteria in the absence of radiographic 
sacroiliitis. 
1.2 New York, 1966 (7) 
Clinical criteria 
1. Limitation of the lumbar spine in all three planes: 
anterior flexion, lateral flexion and extension. 
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2. Pain at the dorsolumbar junction or in the lumbar spine. 
3. Limitation of chest expansion to 2.5 cm or less measured 
at the level of the 4th intercostal space. 
Grading of radiographs 
0 : normal 
1 : suspicious 
2 . minimal sacroiliitis . 
3 . moderate sacroiliitis . 
4 . ankylosis . 
•I 
Definite ankylosing spondylitis defined by grade 3-4 bilateral 
sacroiliitis with at least one clinical criterion OR grade 3-4 
unilateral or grade 2 bilateral sacroiliitis with clinical 
criterion 1 or both clinical criteria 2 and 3. 
Probable ankylosing spondylitis defined~s bilateral sacro-
iliitis in the absence of any clinical criteria. 
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1. 3 Modified New York criteria, 1984 (8) 
1. Low back pain of at least three months duration improved 
by exercise and not relieved by rest. 
2. Limitation of motion of the lumbar spine in sagittal and 
frontal planes. 
3. Chest expansion decreased relative to normal values for 
age and sex. 
4. Bilateral sacroiliitis grade 2-4. 
5. Unilateral sacroiliitis grade 3-4. 
Definite ankylosing spondylitis defined as unilateral grade 
3-4, or bilateral grade 2-4 sacroiliitis and at least one of 
the three clinical criteria. 
2. 
3. 
PSORIATIC ARTHRITIS (9) 
Definition: psoriasis, associated with an inflammatory 
arthritis, which is usually rheumatoid factor negative. 
ENTEROPATHIC ARTHRITIS (10) 
Definition: an inflammatory arthritis induced by, or 
occurring in, the presence of intestinal disease. The 
spectrum of intestinal disease includes: 












4. REITER'S SYNDROME 
4.1 Reiter, 1916 (adapted from 11 and 12) 
A clinical triad of urethritis, arthritis and conjunctivitis 
following dysentry was first described by Stoll in 1776. 
This same triad was noted to follow venereal infection, as 
reported in 1818 by Brodie. Reports by Reiter in 1916, and 
Feissinger and Leroy in the same year, again described the 
same clinical observations following urogenital and gastro-
intestinal infections, respectively. The syndrome was 
finally formally described by Bauer and Engelman in 1942. 
4.2 American RheWllBtis• Association, 1981 (13) 
Definition: an episode of peripheral arthritis of more than 
one month duration, occurring in association with urethritis 
and/or cervicitis. 
5. REACTIVE ARTHRITIS 
5.1 Ahvonen et al, 1969 (14) 
Definition: an episode of acute arthritis developing soon 
after, or during, an infection elsewhere in the body, but in 
which the micro-organism does not enter-the joint. 
5.2 Fan et al, 1993 (11) 
Definition: an episode of peripheral arthritis occurring in 
relation to an infection at a distant site in the body. The 
infectious organism cannot be cultured from joint fluid or 
synovium. The term is restricted to conditions frequently 
associated with HLA-B27, and does not include rheumatic fever, 
Lyme arthritis, parasitic infections and post-viral 
arthritides. 
A P P E N D I X B 
THE EUROPEAN SPOHDYLQARTHROPATHY STUDY GROUP CESSGl CRITERIA 
FOR THE CLASSIFICATION OF SPONDYLQARTHROPATHY (15)* 





predominantly in the lower limbs 
AND 
one or more of the following: 
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urethritis, cervicitis or acute diarrhoea within one 
month before onset of arthritis 
alternating buttock pain , 
enthesitis 
radiographic unilateral (grade 3-4) or bilateral 
(grade 2-4) sacroiliitis** 
* Specifications of all variables of the ESSG criteria for 
spondyloarthropathy are as defined in Appendix D. 
** Radiographic grading of sacroiliitis according to the New 
York criteria, 1966 (7) as detailed in Appendix A. 
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A P P E N D I X C 
SERONEGATIYE SPOHDYLOARTHRQPATHY; DATA CAPl'URE SHEET 
Z1. study number Zl I I I I I 
A1. Surnaae Al I I I I I I I I I I I I I I I 
A2. Initial A2 D 

















Age at onset of symptoms 
Age at time of diagnosis 
Distribution of arthritis 
1. large joints 
2. small joints 
3. spine 
• 
4. large and small joints and spine 
5. large and small joints 
6. large joints and spine 
7. small joints and spine 
8. no evidence of arthritis 
A4 D 





C2. Non-articular musculoskeletal system features 
C2 D 1. tenosynovitis 
2. enthesitis 
3. tenosynovitis and enthesitis 
4. absent/not recorded 
CJ. Gastrointestinal tract features 
1. diarrhoea 
2. IBO 
3. Whipple's disease 
4. absent/not recorded 
C3 D 
C4. Ophthalmic features 
1. uveitis or conjunctivitis 
2. absent/not recorded 
(*indicate in Comments section whether 
conjunctivitis or uveitis present) 
C5. Urogenital tract features 
1. urethritis or cervicitis 
2. genital ulcers 
3. urethritis or cervicitis and genital ulcers 
4. absent/not recorded 
C6. Respiratory features 
1. apical pulmonary fibrosis (previous TB) 
2. apical pulmonary fibrosis (no TB) 
3. chest radiograph normal 
4. chest radiograph not done/not recorded 
C7. Cardiac features 
1. aortic and/or mitral regurgitation 
2. conduction disturbance (ECG) 
3. normal examination 
4. underlying cardiac disease 
cs. Deraatologic features 






2. keratoderma blenorrhagica or pyoderma 
ca D 
gangranosum 
3. normal skin/no comment regarding skin 
4. circinate balanitis 
Inflamaatory back pain 
1. present 
2. absent/not recorded 
Dl. 
Dl D 




3. not recorded 




3. not recorded 




3. not recorded 
El. Complications 
1. spinal fracture 
2. cauda equina syndrome 
El D 
3. myelopathy 
4. none recorded 
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Fl. Family history 




4. unspecified arthritis 
5. relevant family history absent/not recorded 




3. not recorded 




3. not recorded 







(*ring relevant organism/s) 
1. positive 
2. negative 
3. not recorded 




3. degenerative changes only 
4. not recorded/not done 
5. atlanto-axial disease 
H2. Radiographic features: sacroiliac 
1. normal 
2. unilateral abnormality 
H2 D joints • 
3. bilateral abnormalities 
4. suspicious 
5. not recorded/not done 
HJ. Radiographic features: peripheral joints D 
1. normal H3 
2. periarticular osteopaenia (with/without joint 
space narrowing and erosions) 
(*ring osteopaenia, if present on its own) 
3. resorptive changes 
4. not done/not recorded 
5. advanced changes ('destroyed' joint) 
6. other findings 
(**indicate findings (6) in Comments section) 
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Il. Medical therapy D 




5. symptomatic and corticosteroid 
6. symptomatic and DMARD 
7. corticosteroid and DMARD 
8. symptomatic, corticosteroid and DMARD 
I2. Disease modifying anti-rbewnatic drug (DMARD) D 
1. not used I2 
2. sulphasalazine 
3. methotrexate 
4. chloroquine sulphate 
5. combination of agents 
(** indicate agents used in combination (5) 
in Comments section) 
Jl. Joint replacement surgery D 
1. unilateral hip Jl 
2. bilateral hip 
3. other 
(** indicate joint replaced (3) in Comments 
section) 
4. no joint replacement surgery 
Kl. Clinical diagnosis D 
1. ankylosing spondylitis Kl 
2. psoriatic arthropathy 
3. enteropathic arthritis 
4. reactive arthritis 
5. undifferentiated spondyloarthropathy 
Ll. Was diagnosis changed during course of illness? D 
1. yes Ll 
2. no 




DEFINITIONS OF TERMS USED ON DATA CAPTURE SHEET 
Bl • Age at onset of symptoms : age at which one or more of the 
following symptoms were first noted: 
- joint-related pain and/or swelling and/or stiffness 
- early morning stiffness of at least one hour duration 
inflammatory back pain (defined below) 
B2. Age at time of diagnosis age at the time of initial 
evaluation by the RDU at either PACH or GSH. 
c1. Distribution of arthritis: 
Peripheral Arthritis: the presence of joint tenderness and/or 
swelling with or without a capsular pattern of limitation of 
movement at a given joint 
OR 
the presence of established joint deformity(ies) due to previous , 
disease activity, excluding trauma. 
Large joint: hip, knee, ankle, shoulder, elbow, wrist 
Small joint: metacarpophalangeal, interphalangeal, 
metatarsophalangeal 
Spondylitis (Spine) a history of inflammatory back pain 
(defined in Dl) AND limitation of spinal range of movement in 
any plane OR limitation of lumbar spine movement in three planes 
(defined in D2), a positive modified Schober's test (defined in 
D3) or reduced chest expansion (defined in D4). 
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c2. Non-articular musculoskeletal system features: 
Tenosynovitis tenderness on palpation of a particular tendon 
accompanied by pain on resisted movement relevant to the 
particular tendon 
OR 
sausage-shaped digits (dactylitis) due to flexor tenosynovitis 
(83). 
Enthesitis an enthesis (84) is the site of ligamentous 
insertion onto bone occurring at multiple sites in the body (eg. 
attachment of the Achilles tendon to the calcaneus). Non-
granulomatous inflammation at these sites, enthesi tis ( 85), 
results in local fibre disruption with subsequent reactive bone 
formation creating a new enthesis with the eroded end of the 
ligament. Over a period of time ossification of ligaments and 
tendons produces radiographically recognisable 'whiskering' at 
the relevant sites ( 86). For the purposes of this study 
enthesitis was limited to the respective sites of insertion of 
the Achilles tendon and the plantar fascia onto the calcaneus as 
suggested by the ESSG spondyloarthropathy criteria (15). A 
• 
clinic record of spontaneous pain or compression tenderness at 
the site of a relevant enthesis was considered indicative of 
enthesitis at that site. 
C3. Extra-articular features; gastrointestinal tract 
Diarrhoea: an episode of diarrhoea occurring within one month 
before onset of arthritis (15). 
Inflamaatory bowel disease : ulcerative colitis or Crohn's 
disease defined by radiographic barium study and/or histology. 
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Whipple's disease: defined by histologic features on biopsy in 
the appropriate clinical setting. 
c4. Extra-articular features: ophthalmic 
Conjunctivitis : spontaneous onset of a painful red eye with 
preserved visual acuity when seen by a member of the RDU 
OR 
history of such a presentation to a medical practitioner. 
Uveitis: spontaneous onset of a painful red eye with impaired 
visual acuity as assessed by an opthalmologist 
OR 
history of such a presentation and ophthalmological opinion. 
cs. Extra-articular features: urogenital tract 
Urethritis: an episode of urethral discharge occurring within 
one month before onset of arthritis (15). 
Cervicitis: an episode of pelvic inflammatory disease (PIO) 
requiring medical attention occurring one month before onset of 
arthritis (15). 
C6. Respiratory features 
Apical pul.aonary fibrosis as reported on the chest radiograph 
findings was recorded separately in the presence or absence of 
a reported history of pulmonary tuberculosis. A history of 
previous therapy for tuberculosis was considered to indicate 
previous tuberculosis. In the absence of a history of anti-
tuberculosis therapy the presence of apical pulmonary fibrosis 
could not be considered to be exclusively related to previous 
tuberculosis. In the absence of a report of apical 
pulmonary fibrosis, the chest radiograph was recorded as noraal, 
ie. other miscellaneous findings on the radiograph were not 
recorded for the purposes of this study. 
c7. cardiac features 
Aortic and/or aitral. regurgitation or an isolated conduction 
disturbance as reported from an electrocardiogram (ECG), in the 
absence of a history of underlying cardiac disease ( hyper-
tension, rheumatic heart disease, ischaemic heart disease or 
congenital heart disease) was recorded as an extra-articular 
manifestation in the setting of spondyloarthritis. 
cs. Det:110tologic features 
The presence of skin signs (with or without nail changes) 
characteristic of psoriasis OR mucocutaneous features 
compatible with a diagnosis of keratoderaa blenorrbagica, 
pyoderaa gangranOSUJI or circinate bal.anitis as diagnosed by a 
physician. 
Dl. Infln::ewntory back pain: a history of back pain with at least 
four of the following features (87) : 
onset before age 45 
insidious onset 
improved by exercise 
associated with morning stiffness, or 
at least three months duration. 
02. Liaitation of lnmbnJ: spine aoveaent : limitation of lumbar 
spine mobility in three planes: anterior flexion (as defined by 
the modified Schober's test), extension and lateral flexion as 
defined by the New York criteria (7). 
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D3. Modified Schober's test: a minimum length of 20 cm achieved 
( between the upper and lower marks of a pre-measured 15 cm 
lumbar spine segment) on maximal anterior flexion (88) 
indicating at least 5 cm distraction in the lumbar spine 
segment. A recorded value of less than the above was 
considered to be abnormal (89). 
D4. Chest e,cpansion: a chest circumference increase of at least 5 
cm on full inspiration as measured in the 4th intercostal space. 
A value of less that the above was considered to be reduced, as 
defined by the New York criteria (7). 
El. complications 
Spinal :fractures : a description in the clinic notes of a 
radiologically identified segment of spinal architectural 
t 
irregularity owing to the presence of a vertebral fracture 
accompanied by a history of pain relevant to the site of 
observed pathology. Vertebral fracture should have had no 
other identifiable cause (eg. underlying malignancy with bony 
secondary deposits), 
trauma. 
but may have been related to trivial 
• 
Cauda equina syndroae: a description in the clinic notes of 
the slow spontaneous onset of neurological dysfunction related 
to the lower lumbar and sacral dermatomes. 
recorded should include (90) : 
Clinical features 
sensory disturbance (in the relevant dermatomes) 
urinary and/or rectal sphincter dysfunction 
lower limb weakness, and 
pain in the lower extremities. 
97 
Hyelopathy a description in the clinic notes of the 
spontaneous onset of neurological dysfunction of pyramidal tract 
origin below a level of radiologically identifiable vertebral 
column pathology compatible with the term spondylitis (defined 
in Section Hl) and in the absence of any other recognised cause. 
Clinical features recorded should include: 
sensory disturbance relevant to the involved dermatomes 
motor weakness and reflex disturbances relevant to the 
level of involvement, and 
urinary and/or rectal sphincter dysfunction dependent 
upon the level of pathology. 
Fl. f8.Jlily history 
Ankylosing spondylitis, psoriasis or in:flaJD18tory bowel disease 
was recorded to be present in a family member of the·' index case, 
only if such a diagnosis had been made by a medical practitioner 
and confirmed by the relevant investigations. Unsubstantiated 
reports of arthritis in a family member of the index case was 
recorded as unspecified arthritis. 
Gl. Rheumatoid factor 
Rheumatoid factor assayed by sheep cell agglutination (SCAT) and 
latex agglutination was recorded as positive for any detectable 
titre. 
G2. BBPHD leukocyte antigen CBLA)-B2Z status 
The presence of HLA-B27 was recorded as positive if present. 
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G3. Microbiological evaluation 
ChllDl}'dia trachoJllltis: a four fold rise in serum titre or an 
initial titre greater than 1 in 256 was recorded as a positive 
finding. 
Sal.aonella, Shigella, Yersinia and ca.pylobacter: a positive 
stool culture was recorded as a positive finding. 
RADIOGRAPHIC FEATURES 
Specific attention is drawn to the fact that skeletal radiographic 
changes were recorded and classified according to descriptive terms 
used in the clinical notes. Specific grading systems, such as the 
New York grading of sacroiliitis (7) or the Larsen index (91) of 
peripheral joint changes, were not utilised since radiographs were 
not routinely reported upon in this manner in the patient records 
used in this study. 
Hl. Spine 
Spondylitis was defined by descriptions of: ( i) squaring of 
vertebral bodies and/or (ii) syndesmophyte formation or (iii) 
'bamboo' spine changes. 
Degenerative changes was defined by descriptions of: ( i) 
vertebral body osteophyte formation and/or (ii) vertebral disc 
space narrowing and/or (iii) loss of anterior vertebral body 
height. 
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Atlanto-axial disease was defined by descriptions of (i) 
radiological evidence of atlanto-axial instability as 
demonstrated by flexion and extension views of the cervical 
spine (measurement of the atlanto-dens interval) or (ii) 
radiographic evidence of anterior atlanto-axial subluxation 
and/or (iii) radiologically visible erosion of the odontoid peg. 
H2. sacroiliac joints 
Abnoraa.1 sacroiliac joints were defined by descriptions of (i) 
widening or narrowing of the joint space, accompanied by (ii) 
irregular joint margins or (iii) complete ankylosis of the 
sacroiliac joints. Unilateral or bilateral changes were 
recorded separately. 
Descriptions expressing concern regarding the normality of one 
or both sacroiliac joint(s) were recorded as 'suspicious'. 
HJ. Peripheral joints 
Descriptions of (i) periarticular osteopaenia with (ii) joint 
space narrowing and joint margin erosions were recorded as 
'erosive' changes. 
• 
Descriptions of ( i) 'pencil-in-cup' deformities and/or (ii) 
distal phalangeal resorption or (iii) gross disturbances of 
joint architecture due to bone loss of a resorptive nature were 
recorded as resorptive changes. 
Descriptions of advanced non-traumatic post-inflammatory joint 
damage including obliteration of the joint space with or without 
features of joint ankylosis were recorded as advanced 
changes ('destroyed' joint). 
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Miscellaneous other radiographic changes reported in peripheral 
joints were recorded as other findings which were detailed in 
the Comments section at the end of the data capture sheet. 
11. Medical therapy 
Drug therapy as prescribed on prescription charts in the clinic 
notes was recorded in one or more of the following categories: 
(i) syaptoaatic: included all forms of analgesia (non-opiate 
and opiate) and non-steroidal anti-inflammatory agents. 
(ii) corticosteroid included all prescriptions of Q13ll 
therapy. Intra-articular injections of corticosteroid 
therapy were not included in this group. 
(iii) disease-aodifying anti-rheuaatic drug (DlfARD) : included 
sulphasalazine, methotrexate, oral or injectable gold 
preparations and chloroquine sulphate. 
Jl. Joint replacement surgery 
Records of total hip replacement surgery, either unilateral or 
bilateral, were recorded as such. 
Replacement of any other joint, or surgical procedure was 
recorded as other, and detailed in the eomments section at the 
end of the data capture sheet. 
Kl. Clinical diagnosis 
Each patient was assigned a clinical diagnosis from within the 
recognised spondyloarthropathy complex. Details of diagnostic 
criteria or definitions for each disorder are listed in 
Appendices A and B. A change in diagnosis during the course of 
illness was recorded separately. 
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Ml. Duration of disease 
Defined as the time (in years) that had elapsed between the 
onset of symptoms and initial presentation to the RDU, rounded 
off to the nearest six months. 
102 
A P P E N D I X E 
COMPARATIVE DATA; INFLUENCE OF ETHNICITY ON PATTERNS OF DISEASE 
TABLE 17 : Clinical features of spondylitis 
WHITE COLOURED BLACK 
(n=40) (n=53) (n=5) 
Inflammatory 25/40 29/53 3/5 
back pain (62.5) (54.7) (60) 
Reduced spinal 16/38 24/49 3/5 
mobility (42.1) (49) {60) 
Reduced chest 15/24 13/25 3/4 
expansion {62.5) (52) (75) 
Schober's test 15/27 19/33 3/4 
positive (55.6) (57.6) (75) 
Percentage in parenth-• 
t>enoainator • nuaber ot patients in - preaanoa/abaano• or feature vu ,...,.,_ 













TABLE 19: HLA-B27 prevalence 
AS PsA 
(n=20) (n=7) 
White (n=21) 4/9 0/3 
Coloured (n=22) 7/9 1/4 

















TABLE 20(a) : Radiographic features in White patients 
AS PsA EA ReA TOTAL 
(n=13) (n=14) (n=5) (n=B) (n=40) 
Sacroiliac joints 12/12 2/6 0/2 1/5 15/25 
(b=9) (b=l) (b=l) (b=ll) 
Spine 6/8 1/4 0/1 0/4 7/17 
Peripheral joints 2/4 7/9 0/5 0/3 9/21 
(i) 2 6 8 
(ii) 
(iii) 1 1 
• Sacroiliac jointa ( b) • bilateral 
• lpin• C•• l • atlanto-axial ,U-• 
• Peripheral joinU • C 1 l eroa1 .. c:banqaa 
( 11) - -t-infl-tory chanqN 
(1111 rNorptiH Chanqaa 
•I 
TABLE 20(b) . Radiographic features in Coloured patients . 
AS PsA EA ReA Uspa TOTAL 
(n=19) (n=19) (n=2) (n=6) (n=7) (n=53) 
Sacroiliac joints 17/17 3/8 1/1 -0/5 3/7 24/38 
(b=16) (b=3) (b=l) (b=2) (b=22) 
Spine 13/14 4/8 0/2 0/2 17/26 
(aa=3) (aa=3) 
Peripheral joints 8/8 13/17 1/2 0/3 2/5 24/35 
( i) 1 10 1 12 
(ii) 6 2 2 10 
(iii) 1 1 2 
• sacroiliac jointa (bl • bilateral 
• lpin• Caal • atlanto-axial ~
• Peripheral joint& • ( i) eroai .. chanqH 
(11) a49anoad -t-infl-tory chlffl9N 
(111) r .. orptiva cbanqaa 
TABLE 20(c) : Radiographic features in Black 




Sacroiliac joints 3/3 
(b=2) 
Spine 2/2 
Peripheral joints 2/3 
( i ) 
(ii) 2 
(iii) 
• sac:ro111ac ,a1nu (bl • bilataral 
• Spina (u) • atlanto-llldal di• ... • 
• Peripheral ,ainta • (1) eroai•• chanq .. 
( 11 l .- pon-intl._.tory cbanqee 
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Figure 17 : Peripheral arthritis patterns 







• Entheaitia 110re coaaon than tenoaynoviti• in .. 1 .. (p<0.005) and t ... l•• (p<0.005 ) 
Percentage in parm,tb-





MALES (n=71) FEMALES (n=29) 
3 Diarrhoea l 
8 Urethritis OR l 
cervicitis 
2 Circinate balanitis 
1 Keratoderma 
blenorrhagica 
5 Anterior uveitis 2 
3 Conjunctivitis l 
TABLE 25 . HLA-B27 prevalence . 
AS PsA ReA USpA 
(n=20) (n=7) (n=7) (n=ll) 
Males (n=37) 11/19 1/4 6/7 2/7 
Females (n=B) 1/1 0/3 2/4 
(n) • ell petienta within • aubgroup tor whom HLA-1127 rNulta were aYailable. 
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TABLE 26(a) . Radiographic features in males . 
AS PsA EA ReA USpA TOTAL 
(n=29) (n=21) (n=l) (n=ll) (n=9) (n=71) 
Sacroiliac joints 26/26 5/11 0/9 3/7 34/53 
(b=21) (b=5) (b=2) (b=28) 
Spine 17/20 3/7 0/1 0/1 0/3 20/32 
(aa=l) (aa=l) 
Peripheral joints 8/11 12/15 1/1 0/9 1/6 22/42 
(i) 9 1 10 
(ii) 7 2 1 10 
(iii) 1 1 2 
Sacroiliac joints (bl • bilataral 
Spine ( •• l • atlanto-adal ell-• 
Paripbaral joints• Ci) eroai•e cballqN 
Ciil - post-infl-tory cb._ 
( 111) reaorpt1 •• cball9• 
TABLE 26(b) : Radiographic features in females 
AS PsA EA ReA USpA TOTAL 
(n=6) (n=14) (n=l) (n=2) (n=6) (n=29) 
Sacroiliac joints 6/6 0/4 1/1 1/5 8/16 
(b=6) (b=l) • (b=l) (b=8) 
Spine 4/4 2/5 0/1 0/3 6/13 
(aa=2) (aa=l) 
Peripheral joints 4/4 9/12 0/1 1/2 14/19 
( i) 3 8 11 
(ii) 1 1 2 
(iii) 1 1 
Sacroiliac joints Cb)• bilataral 
Spine (aa) • atlanto-axial di••••• 
Peripharal joints • Cil eroai-~ 
c 11 l adYancac! post-1nfl-tory chanqaa 
(111) .--orptiva chan-
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TABLE 27 . Management . 
MALES FEMALES 
(n=71) (n=29) 
37 (80.l) Symptomatic therapy 22 (75.9) 
10 (14.l) DMARDs 6 (20.7) 
Large joint 
arthroplasty . . 
9 (12.7) - number 
of patients 5 (17.2) 
21 (7.4) - number 
of procedures 6 (5.2) 




COMPARATIVE DATA: INFLUENCE OF HLA-B27 OH PATTERNS OF DISEASE 
TABLE 31: Clinical features of spondylitis in 
AS patients of differing HLA-B27 status 
HLA-B27 +ve AS HLA-B27 -ve AS 
(n=12) (n= 8) 
12/12 Inflammatory back 7/8 
pain 
12/12 Reduced spinal 5/8 
mobility 
10/10 Reduced chest 5/7 
expansion 
11/11 Schober's test 5/7 
positive 
Denoainatar • n..-r ot patient:11 in - -enOtl/abaanoa ot r .. tuno ... .-.oorded 
TABLE 32(a) : Radiographic features in HLA-B27 positive 
patients 
AS PsA ReA USpA TOTAL 
(n=l2) (n=l) (n=6) (n=4) (n=23) 
Sacroiliac joints 9/9 1/1 0/5 0/2 10/17 
(b=9) (b=l) (b=lO) 
Spine 11/12 1/1 0/1 0/1 12/15 
Peripheral joints 2/3 1/1 0/5 1/2 4/11 
(i) 
(ii) 2 l 3 
(iii) 1 1 
• sacroiliac jo1~ (bl• bilateral 
• Spin• ( u ) • at.lant<>-e.xial 41• ... • 
• Paripheral jo1~ • Ci) eroai'H chanq-
( 11) advanced poat-intl._.tory --
(111) r .. orpt1•• cbanq .. 
TABLE 32(b) : Radiographic features in HLA-B27 negative 
patients 
AS PsA ReA USpA TOTAL 
(n=8) (n=6) (n=l) (n=7) {n=22) 
Sacroiliac joints 8/8 0/4 0/1 2/7 10/20 
(b=5) (b=l) (b=6) 
Spine 2/3 0/2 0/4 2/9 
Peripheral joints 2/3 3/5 0/4 5/12 
( i) 3 3 
(ii) 1 1 
(iii) 1 1 
• sacroiliac joint& (bl• bilataral 
• Spine (aa) • atlanto-allial diaaaa• 
• Paripbaral joint& • (1) ...... 1- chan9• 
(111 adYanoed poat-intl-tory cba"9•• 
( 111) reaorpt.1- chan9• 
TABLE 33: Management of spondyloarthritis patients of 




3 ( 13) 
4 (17.4) 
9 (39.1) 











• 21 (95.4) 
1 (4.5) 
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